Podcasts about Informa

Rezultatul oricărei alegeri mari se bazează pe procesul prin care ajungi la ea, nu doar pe impulsul de moment. Claritatea este atributul esențial al unui lider, fiindcă trebuie să știi exact unde te afli înainte de a decide încotro vrei să mergi. O metodă practică de a structura gândirea este desenarea sistemelor pe hârtie, proces care forțează creierul să conecteze ideile și să elimine confuzia. Deciziile devin automat mai bune atunci când există conștientizarea că mecanismul din spatele lor va trebui explicat și justificat în fața altora. Modestia intelectuală este motorul evoluției, oferind capacitatea de a pune sub semnul întrebării propriile convingeri și de a accepta posibilitatea erorii. Este mult mai dificil procesul de a te dezvăța de idei vechi decât cel de a învăța lucruri noi, dar această agilitate mentală este necesară pentru a rămâne relevant. În final, responsabilitatea unei alegeri este ca o „bombă” care trebuie gestionată prin analiză, ponderarea criteriilor și controlul emoțiilor. IGDLCC înseamnă Informații Gratis despre Lucruri care Costă! Totul ne costă dar mai ales timpul așa că am făcut această serie pentru a mă informa și educa alături de invitați din domeniile mele de interes. Te invit alături de mine în această călătorie. Mi-am propus să mă facă mai informat și mai adaptat la schimbările care vin. Sper să o facă și pentru tine.

⁠⁠⁠Enio Augusto⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ e ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Marcos Buosi⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ falam sobre tudo que envolve o mundo dos tênis e também de outros acessórios relacionados à corrida.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠SEJA MEMBRO DO CANAL!!!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Aqui tem análises, reviews, dicas, palpites, perguntas, respostas, números, valores e opinião. Informação com bom humor, dúvidas com resposta e conteúdo de sobra. Envie sua pergunta. Escute, aprenda, ensine e divirta-se com a gente.-Qual tênis você escolheria para ganhar de aniversário?Superblast e Evo SL tem a mesma proposta? Qual é mais “faz tudo”?Alguns dos últimos lançamentos.Puma Deviate Nitro Elite 4.Olympikus Corre Pace.Mizuno Neo Zen 2.Asics Magic Speed 5.New Balance 1080 v15.Fila Speedrocker com a nova espuma Skyfoam.Adidas Supernova Rise 3.Adidas Supernova Glide.-Cupom de Desconto:⁠⁠⁠⁠⁠⁠⁠⁠⁠CORRA BARATO⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ - PFC⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠KEEP RUNNING BRASIL⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ - PFC

Bienvenidos a Andalucía Informa, un podcast de Europa Press. En este espacio podrás conocer en unos minutos las noticias más relevantes de nuestra comunidad. Hoy es 25 de febrero y estas son algunas de las informaciones más destacadas en nuestra agencia. La Junta mueve 214,7 millones del Presupuesto 2026 para destinarlos al Plan Andalucía Actúa y descarta recortes El alcalde de Grazalema (Cádiz) avisa tras la vuelta de los últimos vecinos desalojados: "Queda mucha tarea" El CEO de Ikea, Eva González, el director de Ciberseguridad de Google y las UCI pediátricas, Medallas de Andalucía 2026 Interior deniega la condición de víctima del terrorismo a García Caparrós, asesinado en Málaga por la policía en 1977 Recuerda que puedes encontrar estas y otras muchas noticias en la sección de Andalucía en nuestra web europapress.es. 

O consumo de maconha no Brasil dobrou nos últimos dez anos, e entre as mulheres, triplicou. Esses são dados do Lenad III, o maior levantamento sobre drogas já feito no país, que mostrou, ainda, que mais de 90% desse consumo crescente é fumado. Os dados chegaram para complicar aquela narrativa de que o Brasil canábico que emerge é o do óleo e do CBD.No episódio 102 do Cannabis Hoje Pod eu conversei com Clarice Madruga, pesquisadora da Unifesp que coordenou o Lenad III, e destrinchou outros achados interessantes. Por exemplo, quanto maior a renda e a escolaridade, maior a chance de a pessoa já ter experimentado maconha no Brasil. Será, a erva, afinal, uma droga de playboy? Pois é, a proibição nunca foi um problema igual para todo mundo.A gente também entrou num território que eu adoro: a suposta polarização entre pesquisadores de drogas, com conservadores de um lado e redutores de danos do outro. Clarice desafia essa narrativa dizendo que quem estuda de verdade a cannabis mais concorda do que discorda e que os extremos barulhentos estão na população leiga, não na ciência. Aperta o play que hoje tem dado, contexto e a visão de quem passou anos pesquisando o uso de substâncias no Brasil!***Encontre a Claricehttps://www.linkedin.com/in/claricemadruga/***Clarice indicaObservatório Brasileiro de Informações sobre Drogas (OBID)***MARCAS APOIADORAS DA 5ª TEMPORADAEssas são marcas que valorizam a comunicação responsável e o jornalismo de excelência como pilares para orientar o desenvolvimento do setor.AbecMed: https://abecmed.com.br/Master Plants: https://masterplants.com.br/USA Hemp: https://www.usahempbrasil.com/aLeda: https://aleda.com.br/Blis: https://appblis.com.br/***Para seguir por dentro dos avanços da cannabis e dos psicodélicosAssine a news: https://cannabishoje.substack.com/Siga no Insta: https://www.instagram.com/cannabishoje/Se inscreva no Youtube: https://www.youtube.com/@cannabishojeAcesse: https://cannabishoje.com.br/

Informa de la puntualización sobre el derribo del Azud de Puente Mesa.

Bienvenidos a Andalucía Informa, un podcast de Europa Press. En este espacio podrás conocer en unos minutos las noticias más relevantes de nuestra comunidad. Hoy es 24 de febrero y estas son algunas de las informaciones más destacadas en nuestra agencia. La jueza que investiga el accidente de Adamuz pide a Adif que "se abstenga de realizar cualquier operación" sobre las vías sin autorización  El Ministerio defiende que retirar el material de Adamuz ha evitado que desaparezca y sea "achatarrado" La Junta de Andalucía aprobará este miércoles un paquete de bajadas fiscales para familias afectadas por el tren de borrascas Recuerda que puedes encontrar estas y otras muchas noticias en la sección de Andalucía en nuestra web europapress.es. 

Succesul autentic vine din curajul de a experimenta și de a testa idei noi fără teama de a eșua în fața publicului. Este esențial să ne oprim periodic din agitația zilnică pentru a învăța lucruri noi și pentru a ne verifica sistemul de valori personale. Tehnologia modernă și inteligența artificială trebuie privite ca unelte puternice care ne ajută să ne transformăm viziunile în realitate mult mai rapid decât în trecut. În același timp, educația trebuie să evolueze spre un model personalizat, adaptat nevoilor și ritmului unic al fiecărui individ. Oamenii care au atins succesul au datoria morală de a sprijini comunitatea și de a împărtăși experiența lor celor aflați la început de drum. Societatea ar funcționa mult mai eficient dacă s-ar baza pe competență și pe respectarea cuvântului dat, în locul birocrației rigide. În final, viitorul nostru depinde în mod direct de capacitatea de a rămâne curioși și de a ne adapta constant la schimbările accelerate ale lumii. IGDLCC înseamnă Informații Gratis despre Lucruri care Costă! Totul ne costă dar mai ales timpul așa că am făcut această serie pentru a mă informa și educa alături de invitați din domeniile mele de interes. Te invit alături de mine în această călătorie. Mi-am propus să mă facă mai informat și mai adaptat la schimbările care vin. Sper să o facă și pentru tine.

A edição de hoje destaca o I Fórum de Cirurgia Bariátrica e Metabólica do CFM, que discute estratégias para ampliar o acesso qualificado ao tratamento da obesidade no SUS. O boletim traz também o alerta do CDC sobre o aumento de casos graves e óbitos por influenza em crianças não vacinadas. Por fim, apresentamos a atualização da OMS sobre o surto multicêntrico de cólera, que mantém o risco global em nível muito alto. Acompanhe as notícias que impactam a gestão da linha de cuidado e a vigilância epidemiológica no seu podcast diário de atualização, com curadoria médica e produzido por IA.Afya News. Informação médica confiável e atualizada no seu tempo.Fontes do episódio aqui:⁠https://portal.afya.com.br/podcasts/afya-news/23-02-2026

Informa sobre la falta de efectivos y mala planificación del servicio de extinción de incendios.

Bienvenidos a Andalucía Informa, un podcast de Europa Press. En este espacio podrás conocer en unos minutos las noticias más relevantes de nuestra comunidad. Hoy es 23 de febrero y estas son algunas de las informaciones más destacadas en nuestra agencia. Moreno se reafirma en "agotar la legislatura" y convocar las andaluzas en junio "salvo que ocurra algo anormal" El onubense Manuel Carrasco y la sevillana Paz Vega, Hijos Predilectos de Andalucía este próximo 28F Cae en Almería una red que cobraba hasta 1.200 euros por empadronamientos falsos a migrantes Recuerda que puedes encontrar estas y otras muchas noticias en la sección de Andalucía en nuestra web europapress.es. 

O programa MusicArte recebeu Isabel Pereira, da Info-Zenter Demenz, para uma conversa especial a propósito da exibição do filme Mãe, do realizador madeirense João Brás.Nesta entrevista, foi abordada a importância do cinema como ferramenta de sensibilização para a temática da demência, refletindo sobre o impacto social e humano do filme, bem como o papel da cultura na promoção do diálogo e da inclusão.Informações no site da associação.

El presidente de Ucomur ha mantenido recientemente una serie de reuniones clave con la Comisión Europea y en Turín para defender el modelo cooperativo ante los futuros escenarios económicos. La principal preocupación radica en el borrador del marco financiero plurianual para el periodo 2028-2034, cuyas negociaciones con los gobiernos se desarrollarán entre este año y el próximo.Según ha advertido Pedreño, el borrador plantea agrupar diversos programas de financiación en solo 16 programas generales. Esta reestructuración podría suponer una reducción del presupuesto dedicado al ámbito social. El presidente de Ucomur subraya que esta disminución afectaría significativamente a las empresas y proyectos europeos, especialmente en regiones como Murcia, que recibe fondos fundamentales de la PAC y el Fondo Social Europeo. En sus encuentros con los responsables europeos, Pedreño destacó que el 95% de los ciudadanos europeos considera que todas las empresas deberían guiarse por valores como la gobernanza democrática y la redistribución de beneficios. Asimismo, defendió que la economía social es una herramienta clave para recuperar la autonomía estratégica de Europa, permitiendo fabricar productos esenciales dentro del continente y reduciendo la dependencia de mercados externos como Estados Unidos o Asia. El reto para la Unión Europea, según Pedreño, es recuperar competitividad sin sacrificar la cohesión social ni los valores fundacionales que representa el modelo cooperativo.Por otro lado, la agenda de Ucomur para las próximas semanas se presenta intensa, con el foco puesto en el trabajo interno para mejorar la cualificación de los trabajadores y la competitividad de las empresas. Entre las actividades destacadas se encuentran una jornada sobre comunidades energéticas en Fuente Álamo (3 de marzo), la asamblea de cooperativas de enseñanza (12 de marzo) y la feria de cooperativas escolares en Cartagena (18 de marzo). Además, la organización tendrá una proyección internacional relevante al participar en la presentación del primer plan de acción latinoamericano de economía social en Uruguay.

Nesta edição de domingo, a Prescrição Cultural explora questões de identidade e terminalidade através da obra "O Ano em que Disse Sim à Vida", do neurocirurgião Paul Kalanithi. O conteúdo aborda as lições de liderança baseada em empatia na série "Ted Lasso" e o equilíbrio entre técnica e humanidade na docussérie "The Surgeon's Cut". Para encerrar, apresentamos a sonoridade solar e sofisticada de Marina Sena para renovar os ânimos. Aproveite estas indicações para expandir seu repertório humanístico e refletir sobre o cuidado além do prontuário no seu podcast diário de atualização, com curadoria médica e produzido por IA.Afya News. Informação médica confiável e atualizada no seu tempo.Fontes do episódio aqui:⁠https://portal.afya.com.br/podcasts/afya-news/22-02-2026

O balanço desta semana destaca os alertas de saúde pós-Carnaval, incluindo a vigilância para síndromes febris e o impacto de eventos de massa nas emergências. O episódio recapitula os avanços na medicina preditiva com o uso da proteína p-tau217 para estimar o início do Alzheimer e a associação entre o consumo de cafeína e o menor risco de demência. Trazemos também os resultados do anticoagulante asundexiano e a transição da insulina NPH para a glargina de longa duração no SUS. Acompanhe a síntese das notícias que impulsionam a eficiência e a tecnologia na prática médica no seu podcast diário de atualização, com curadoria médica e produzido por IA.Afya News. Informação médica confiável e atualizada no seu tempo.Fontes do episódio aqui:⁠https://portal.afya.com.br/podcasts/afya-news/21-02-2026

Experiența noastră subiectivă nu este o reacție directă la realitatea obiectivă, ci o construcție activă a creierului, care editează continuu percepțiile pentru a crea un „film” coerent al lumii. Emoțiile nu sunt mecanisme universale înnăscute sau entități biologice fixe, ci sunt etichete culturale și lingvistice pe care le aplicăm unor senzații fizice de bază, numite interocepție. Acest proces de construcție depinde fundamental de context, educație și mediul social, ceea ce explică de ce culturile non-occidentale pot experimenta stări interne complet diferite de ale noastre. La nivel biologic, sistemul imunitar joacă un rol central în generarea semnalelor pe care le interpretăm drept emoții negative sau alerte de pericol. Sănătatea mentală este strâns legată de „alostază”, procesul predictiv prin care creierul gestionează bugetul de energie al corpului pentru a face față provocărilor viitoare. Atunci când aceste mecanisme de adaptare sunt suprasolicitate sau devin imprevizibile, apare stresul cronic și inflamația, care pot conduce în final la stări precum depresia. În concluzie, suntem sisteme biologice complexe care funcționează optim doar atunci când reușim să menținem un echilibru între predicțiile minții și nevoile energetice ale organismului. IGDLCC înseamnă Informații Gratis despre Lucruri care Costă! Totul ne costă dar mai ales timpul așa că am făcut această serie pentru a mă informa și educa alături de invitați din domeniile mele de interes. Te invit alături de mine în această călătorie. Mi-am propus să mă facă mai informat și mai adaptat la schimbările care vin. Sper să o facă și pentru tine.

Nesta edição, destacamos uma nova técnica de exame de sangue capaz de prever o início dos sintomas de Alzheimer com anos de antecedência e a associação entre o consumo de café ou chá e a redução do risco de demência. O conteúdo apresenta também os resultados promissores do anticoagulante asundexiano na prevenção secundária de AVC isquêmico. Acompanhe as atualizações que aprimoram o rastreamento neurológico e a segurança terapêutica no seu podcast diário de atualização, com curadoria médica e produzido por IA.Afya News. Informação médica confiável e atualizada no seu tempo.Fontes do episódio aqui:⁠https://portal.afya.com.br/podcasts/afya-news/20-02-2026

O caso Epstein continua a deixar marcas no Reino Unido, desta vez com a detenção do ex-príncipe André, irmão do rei Carlos III. Suspeito de ter partilhado com o pedófilo e seu amigo Jeffrey Epstein informações confidenciais comerciais, foi libertado no mesmo dia. Nos EUA não há para já interrogatórios aos vários nomes referidos no processo. José Eduardo Martins admite que nos sentíamos “protegidos de alguns horrores”, Pedro Delgado Alves explica que já se conhecem “ligações fortes à Rússia”. Ouça a análise dos comentadores no Antes Pelo Contrário em podcast, emitido na SIC Notícias a 19 de fevereiro. Para ver a versão vídeo deste episódio clique aquiSee omnystudio.com/listener for privacy information.

Melissa Lavasani & Jay Kopelman join our podcast to discuss how psychedelic policy is actually moving in Washington, DC. Lavasani leads Psychedelic Medicine Coalition, a DC-based advocacy organization focused on educating federal officials and advancing legislation around psychedelic medicine. Kopelman is CEO of Mission Within Foundation, which provides scholarships for veterans and first responders seeking psychedelic-assisted therapy retreats, often outside the United States. The conversation centers on veterans, the VA, and why that system may be the first realistic federal pathway for psychedelic care. Early Themes Lavasani describes PMC's work on Capitol Hill, including hosting events that bring lawmakers, staffers, and advocates into the same room. Her focus is steady engagement. In DC, progress often happens through repeated conversations, not headlines. Kopelman shares his background as a Marine and how his own psychedelic-assisted therapy experience led him to Mission Within. The foundation has funded more than 250 scholarships for veterans and first responders seeking treatment for PTSD, mild traumatic brain injury, depression, and addiction. They connect this work to pending veteran-focused legislation and explain why the VA matters. As a closed health system, the VA can pilot programs, gather data, and refine protocols without the pressures of private healthcare markets. Core Insights A recent Capitol Hill gathering, For Veteran Society, brought together members of Congress and leaders from the psychedelic caucus. Lavasani describes candid feedback from lawmakers. The message was clear: coordinate messaging, avoid fragmentation, and move while bipartisan interest remains. Veteran healthcare is not framed as the final goal. It is a starting point. If psychedelic therapies can demonstrate safety and effectiveness within the VA, broader adoption becomes more plausible. Kopelman raises operational realities that must be addressed: Standardized safety protocols across providers Integration support, not medication alone Clear training pathways for clinicians Real-world data beyond tightly screened clinical trials They also address recent negative headlines involving ibogaine treatment abroad. Kopelman emphasizes the need for shared learning across providers, especially when adverse events occur. Lavasani argues that inconsistency within the ecosystem can slow federal confidence. Later Discussion and Takeaways The discussion widens to federal momentum around addiction and mental health. Lavasani notes that new funding initiatives signal growing openness to innovative treatment models, even if psychedelics are not named explicitly in every announcement. Both guests stress that policy moves slowly by design. Meetings, follow-ups, and relationship building often matter more than public statements. For clinicians, researchers, operators, and advocates, the takeaways are direct: Veterans are likely the first federal pathway Public education remains essential Safety standards must be shared and transparent Integration and workforce development need attention now If psychedelic medicine enters federal systems, infrastructure will determine success. Frequently Asked Questions What do Melissa Lavasani & Jay Kopelman say about VA psychedelic policy? They argue that veteran-focused legislation offers a realistic first federal pathway for psychedelic-assisted care. Is ibogaine currently available through the VA? No. They discuss ibogaine in the context of private retreats and future possibilities, not an existing VA program. Why do Melissa Lavasani & Jay Kopelman emphasize coordination? Lawmakers respond more positively when advocates present aligned messaging and clear priorities. What safety issues are discussed by Melissa Lavasani & Jay Kopelman? They highlight the need for standardized screening, monitoring, integration support, and transparent review of adverse events. Closing Melissa Lavasani & Jay Kopelman provide a grounded look at how psychedelic policy develops inside federal systems. Their message is practical: veterans may be the first lane, but long-term success depends on coordination, safety standards, and sustained engagement. Closing This episode captures a real-time view of how federal policy could shape the next phase of the psychedelic resurgence, especially through veteran-facing legislation and VA infrastructure. Melissa Lavasani & Jay Kopelman argue that coordination, public education, and shared safety standards will shape whether access expands with credibility and care. Transcript Joe Moore: [00:00:00] Hello everybody. Welcome back to Psychedelics Today. Today we have two guests, um, got Melissa Sani from Psychedelic Medicine Coalition. We got Jake Pelman from Mission Within Foundation. We're gonna talk about I bga I became policy on a recent, uh, set of meetings in Washington, DC and, uh, all sorts of other things I'm sure. Joe Moore: But thank you both for joining me. Melissa Lavasani: Thanks for having us. Jay Kopelman: Yeah, it's a pleasure. Thanks. Joe Moore: Yeah. Um, Melissa, I wanna have you, uh, jump in. First. Can you tell us a little bit about, uh, your work and what you do at PMC? Melissa Lavasani: Yeah, so Psychedelic Medicine Coalition is, um, the only DC based Washington DC based advocacy organization dedicated to the advancing the issue of psychedelics, um, and making sure the federal government has the education they need, um, and understands the issue inside out so that they can generate good policy around, around psychedelic medicines. Melissa Lavasani: [00:01:00] Uh, we. Host Hill events. We host other convenings. Our big event every year is the Federal Summit on psychedelic medicine. Um, that's going to be May 14th this year. Um, where we talk about kinda the pressing issues that need to be talked about, uh, with government officials in the room, um, so that we can incrementally move this forward. Melissa Lavasani: Um, our presence here in Washington DC is, is really critical for this issue's success because, um, when we're talking about psychedelic medicines, um, from the federal government pers perspective, you know, they are, they are the ones that are going to initiate the policies that create a healthcare system that can properly facilitate these medicines and make sure, um, patient safety is a priority. Melissa Lavasani: And there's guardrails on this. And, um, you know, there, it's, it's really important that we have. A home base for this issue in Washington DC just [00:02:00] because, uh, this is very complicated as a lot of your viewers probably understand, and, you know, this can get lost in the mix of all the other issues that, um, lawmakers in DC are focused on right now. Melissa Lavasani: And we need to keep that consistent presence here so that this continues to be a priority for members of Congress. Joe Moore: Mm. I love this. And Jay, can you tell us a bit about yourself and mission within Foundation? Jay Kopelman: Yeah, sure. Joe, thanks. Uh, I, I am the CEO of Mission within Foundation. Prior to this, most of my adult life was spent in the military as a Marine. Jay Kopelman: And I came to this. Role after having, uh, a psychedelic assisted therapy experience myself at the mission within down in Mexico, which is where pretty much we all go. Um, we are here to help [00:03:00] provide, uh, access for veterans and first responders to be able to attend psychedelic assisted therapy retreats to treat issues like mild TBI, post-traumatic stress disorder, uh, depression, sometimes addiction at, at a very low level. Jay Kopelman: Um, and, and so we've, we've been doing this for a little more than a year now and have provided 250 plus scholarships to veterans and first responders to be able to access. These retreats and these, these lifesaving medicines. Um, we're also partnered, uh, you may or may not know with Melissa at Psychedelic Medicine Coalition to help advance education and policy, specifically the innovative, uh, therapy Centers of Excellence Act [00:04:00] that Melissa has worked for a number of years on now to bring to both Houses of Congress. Joe Moore: Thank you for that. Um, so let's chat a little bit about what this event was that just, uh, went down, uh, what, what was it two weeks ago at this point? Melissa Lavasani: Yeah. Yeah. It's called For Veteran Society and it's all, um, there's a lot of dialogue on Capitol Hill about veterans healthcare and psychedelics, but where I've been frustrated is that, you know, it was just a lot of. Melissa Lavasani: Talk about what the problems are and not a lot of talk about like how we actually propel things forward. Um, so it, at that event, I thought it was really important and we had three members of Congress there, um, Morgan Latrell, who has been a champion from day one and his time in Congress, um, having gone through the experience himself, um, [00:05:00] at Mission within, um, and then the two chairs of the psychedelic caucus, uh, Lou Correa and Jack Bergman. Melissa Lavasani: And we really got down to the nitty gritty of like w like why this has taken so long and you know, what is actually happening right now? What are the possibilities and what the roadblocks are. And it was, I thought it was a great conversation. Um, we had an interesting kind of dynamic with Latres is like a very passionate about this issue in particular. Melissa Lavasani: Um, I think it was, I think it was really. A great event. And, you know, two days later, Jack Bergman introduced his new bill for the va. Um, so it was kind of like the precursor to that bill getting introduced. And we're just excited for more and more conversations about how the government can gently guide this issue to success. Joe Moore: Hmm. Yeah. [00:06:00] That's fantastic. Um, yeah, I was a little bummed I couldn't make it, but next time, I hope. But I've heard a lot of good things and, um, it's, it sounded like there was some really important messages in, in terms of like feedback from legislators. Yeah. Yeah. Could you speak to that? Melissa Lavasani: Yeah, I mean, I think when, uh, representative Latrell was speaking, he really impressed on us a couple things. Melissa Lavasani: Um, first is that, you know, they really kind of need the advocates to. Coordinate, collaborate and come up with like a, a strategic plan, you know, without public education. Um, talking to members of Congress about this issue is, is really difficult. You know, like PMC is just one organization. We're very little mission within, very little, um, you know, we're all like, kind of new in navigating, um, this not so new issue, but new to Washington DC [00:07:00] issue. Melissa Lavasani: Um, without that public education as a baseline, uh, it's, it's, you have to spend a lot of time educating members of Congress. You know, that's like one of our things is, you know, we have to, we don't wanna tell Congress what direction to go to. We wanna provide them the information so they understand it very intimately and know how to navigate through things. Melissa Lavasani: Um, and secondly. Um, he got pretty frank with us and said, you know, we've got one cha one chance at this issue. And it's like, that's, that's kind of been like my talking point since I started. PMC is like, you have a very limited window, um, when these kind of issues pop up and they're new and they're fresh and you have a lot of the veteran community coming out and talking about it. Melissa Lavasani: And there's a lot of energy there. But now is the time to really move forward, um, with some real legislation that can be impactful. Um, but, you know, we've gotta [00:08:00] be careful. We, we forget, I think sometimes those of us who are in the ecosystem forget that our level of knowledge about these medicines and a lot of us have firsthand experience, um, with these drugs and, and our own healing journeys is, um, we forget that there is a public out there that doesn't have the level of knowledge that we all have. Melissa Lavasani: And, um. We gotta make sure that we're sticking to the right elements of, of, of what needs to happen. We need to be sure that our talking points are on track and we're not getting sideways about anything and going down roads that we don't need to talk about. It's why, um, you know, PMC is very focused on, um, moving forward veteran legislation right now. Melissa Lavasani: Not because we're a veteran organization, but because we're, we see this long-term policy track here. Um, we know where we want to get [00:09:00] to, um. Um, and watching other healthcare issues kind of come up and then go through the VA healthcare system, I think it's a really unique opportunity, um, to utilize the VA as this closed system, the biggest healthcare system in the country to evaluate, uh, how psychedelics operate within systems like that. Melissa Lavasani: And, you know, before they get into, um, other healthcare systems. What do we need to fix? What do we need to pay attention to? What's something that we're paying too much attention to that doesn't necessarily need that much attention? So it's, um, it's a real opportunity to look at psychedelic medicines within a healthcare system and obviously continue to gather the data. Melissa Lavasani: Um, Bergman's Bill emerging, uh, expanding veteran access to emerging treatments. Um, not only mandates the research, it gives the VA authority for this, uh, for running trials and, and creating programs around psychedelic medicines. But also, [00:10:00] one of the great things about it, I think, is it provides an on-ramp for veterans that don't necessarily qualify for clinical trials. Melissa Lavasani: You know, I think that's one of the biggest criticisms of clinical trials is like you're cre you're creating a vacuum for people and people don't live in a vacuum. So we don't necessarily know what psychedelics are gonna look like in real life. Um, but with this expanding veteran access bill that Bergman introduced, it provides the VA an opportunity to provide this access under. Melissa Lavasani: Um, in a, in a safe container with medical supervision while collecting data, um, while ensuring that the veteran that is going through this process has the support systems that it needs. So, um, you know, I think that there's a really unique opportunity here, and like Latrell said, like, we've got one shot at this. Melissa Lavasani: We have people's attention in Congress. Um, now's the time to start acting, and let's be really considerate and thoughtful about what we're doing with it. Joe Moore: Thanks for that, Melissa and Jay, how, [00:11:00] anything to add there on kind of your takeaways from the this, uh, last visit in dc? Jay Kopelman: Yeah, I, I think that Melissa highlighted it really well and there, there were a couple other things that I, I think, you know, you could kind of tie it all together with some other issues that we face in this country, uh, and that. Jay Kopelman: Uh, representative Correa brought up as well, but one of the things I wanted to go back and say is that veterans have kind of led this movement already, right? So, so it's a, it's a good jumping off point, right? That it's something people from both sides of the aisle, from any community in America can get behind. Jay Kopelman: You know, if you think about it, uh, in World War ii, you know, we had a million people serving our population was like, not even 200 million, but now [00:12:00] we have a population of 330 million, and at any given time there might be a million people in uniform, including the Reserve and the National Guard. So it's, it, it's an easy thing to get behind this small part of the population that is willing to sign that contract. Jay Kopelman: Where you are saying, yeah, I'm going to defend my country, possibly at the risk of my l my own life. So that's the first thing. The other thing is that the VA being a closed health system, and they don't have shareholders to answer to, they can take some risks, they can be innovative and be forward thinking in the ways that some other healthcare systems can't. Jay Kopelman: And so they have a perfect opportunity to show that they truly care for their veterans, which don't, I'm not saying they don't, but this would be an [00:13:00] opportunity to show that carrot at a whole different level. Uh, it would allow them to innovate and be a leader in something as, uh, as our friend Jim Hancock will say, you know. Jay Kopelman: When he went to the Naval Academy, they had the world's best shipbuilding program. Why doesn't the VA have the world's best care program for things like TBI and PTSD, which affects, you know, 40 something percent of all veterans, right? So, so there's, there's an opportunity here for the VA to lead from the front. Jay Kopelman: Um, the, these medicines provide, you know, reasonably lasting care where it's kind of a one and done. Whereas with the current systems, the, you know, and, and [00:14:00] again, not to denigrate the VA in any way, they're doing the best job they can with the tools in their toolbox, right? But maybe it's time for a trip to Home Depot. Jay Kopelman: Let's get some new tools. And have some new ways of fixing what's broken, which is really the way of doing things. It's not, veterans aren't broken, we are who we are. Um, but it's a, it's a way to fix what isn't working. So I, I think that, you know, given there's tremendous veteran homelessness still, you know, addiction issues, all these things that do translate to the population at large are things that can be worked on in this one system, the va that can then be shown to have efficacy, have good data, have [00:15:00] good outcomes, and, and take it to the population at large. Joe Moore: Mm-hmm. Brilliant. Thanks for that. And so there was another thing I wanted to pivot to, which is some of the recent press. So we've, um, seen a little bit of press around some, um, in one instance, some bad behavior in Mexico that a FI put out Americans thrive again, put out. And then another case there was a, a recent fatality. Joe Moore: And I think, um, both are tragic. Like we shouldn't be having to deal with this at this point. Um, but there's a lot of things that got us here. Um, it's not necessarily the operator's fault entirely, um, or even at all, honestly, like some medical interventions just carry a lot of risk. Like think, think about like, uh, how risky bypass surgery was in the nineties, right? Joe Moore: Like people were dying a lot from medical interventions and um, you know, this is a major intervention, uh, ibogaine [00:16:00] and also a lot of promise. To help people quite a bit. Um, but as of right now, there's, there's risk. And part of that risk, in my opinion, comes from the inability of organizations to necessarily collaborate. Joe Moore: Like there's no kind of convening body, sitting in the middle, allowing, um, for, and facilitating really good data sharing and learnings. Um, and I don't, I don't necessarily see an organization stepping up and being the, um, the convener for that kind of work. I've heard rumors that something's gonna happen there, and I'm, I'm hopeful I'll always wanna share my opinion on that. Joe Moore: But yeah. I don't know. Jay, from your perspective, is there anything you want to kind of speak to about, uh, these two recent incidents that Americans for Iboga kind of publicized recently? Jay Kopelman: Yeah, so I, I'll echo your sentiment, of course, that these are tragic incidents. Um, and I, [00:17:00] I think that at least in the case of the death at Ambio, AMBIO has done a very good job of talking about it, right? Jay Kopelman: They've been very honest with the information that they have. And like you said, there are risks inherent to these medicines, and it's like anything else in medicine, there are going to be risks. You know, when I went through, uh, when I, when I went through chemo, you know, there were, there are risks. You know, you don't feel well, you get sick. Jay Kopelman: Um, and, and it. There are processes in place to counter that when it happens. And there are processes and, and procedures and safety protocols in place when caring for somebody going through an ibogaine [00:18:00] journey. Uh, when I did it, we had EKG echocardiogram. You're on a heart monitor the entire time they push magnesium via iv. Jay Kopelman: You have to provide a urinalysis sample to make sure that there is nothing in your system that is going to potentially harm you. During the ibogaine, they have, uh, a cardiologist who is monitoring the heart monitors throughout the ibogaine experience. So the, the safety protocols are there. I think it's, I think it's just a matter of. Jay Kopelman: Standardizing them across all, all providers, right? Like, that would be a good thing if people would talk to one another. Um, as, as in any system, right? You've gotta have [00:19:00] some collaboration. You've gotta have standardization, you know, so, you know, they're not called standard operating procedures for nothing. Jay Kopelman: That means that in a, you know, in a given environment, everybody does things the same way. It's true in Navy and Marine Corps, air Force, army Aviation, they have standard operating procedures for every single aircraft. So if you fly, let's say the F 35 now, right? Because it's flown by the Navy, the Marine Corps, and the Air Force. Jay Kopelman: The, the emergency procedures in that airplane are standardized across all three services, so you should have the same, or, you know, with within a couple of different words, the same procedures and processes [00:20:00] across all the providers, right? Like maybe in one document you're gonna change, happy to glad and small dog to puppy, but it's still pretty much the, the same thing. Jay Kopelman: And as a service that provides scholarships to people to go access these medicines and go to these retreats, you know, my criteria is that the, this provider has to be safe. Number one, safety's paramount. It's always gotta be very safe. It should, it has to be effective. And you know, once you have those two things in place, then I have a comfort level saying, okay, yeah, we'll work with this provider. Jay Kopelman: But until those standardized processes are in place, you'll probably see these one-off things. I mean, some providers have been doing this longer than others and have [00:21:00] really figured out, you know, they've, they've cracked the code and, you know, sharing that across the spectrum would be good. Um, but just when these things happen, having a clearing house, right, where everybody can come together and talk about it, you know, like once the facts are known because. Jay Kopelman: To my knowledge, we still don't know all the facts. Like as, you know, as horrible as this is, you still have to talk about like an, has an autopsy been performed? What was found in the patient's system? You know, there, there are things there that we don't know. So we need to, we need to know that before we can start saying, okay, well this is how we can fix that, because we just don't know. Jay Kopelman: And, you know, to their credit, you know, Amio has always been safe to, to the, to the best of my knowledge. You know, I, [00:22:00] I haven't been to Ambio myself, but people that I have worked with have been there. They have observed, they have seen the process. They believe it's safe, and I trust their opinion because they've seen it elsewhere as well. Jay Kopelman: So yeah, having, having that one place where we can all come together when this happens, it, it's almost like it should be mandatory. In the military when there's a training accident, we, you know, we would have to have what's called a safety standout. And you don't do that again for a little while until you figure out, okay, how are we going to mitigate that happening again? Jay Kopelman: Believe me, you can go overboard and we don't want to do that. Like, we don't wanna just stop all care, but maybe stop detox for a week and then come back to it. [00:23:00] Joe Moore: Yeah. A dream would be, let's get like the, I don't know, 10, 20 most popular, uh, or well-known operators together somewhere and just do like a three day debrief. Joe Moore: Hey, everybody, like, here's what we see. Let's work on this together. You know how normal medicine works. And this is, it's hard because this is not necessarily, um, something people feel safe about in America talking about 'cause it's illicit here. Um, I don't understand necessarily how the operations, uh, relate to each other in Mexico, but I think that's something to like the public should dig into. Joe Moore: Like, what, what is this? And I, I'll start digging into that. Um, I, I asked a question recently of somebody like, is there some sort of like back channel signal everybody's using and there's no clear Yes. You know? Um, I think it would be good. That's just a [00:24:00] start, you know, that's like, okay, we can actually kind of say hi and watch out for this to each other. Jay Kopelman: It's not like we don't all know one another, right? Joe Moore: Yes. Jay Kopelman: Like at least three operators we're represented. At the Aspen Ibogaine meeting. So like that could be, and I think there was a panel kind of loosely related to this during Aspen Ibogaine meeting, but Joe Moore: mm-hmm. Jay Kopelman: It, you know, have a breakout where the operators can go sit down and kind of compare notes. Joe Moore: Right. Yeah. Melissa, do you have any, uh, comments on this thread here? And I, I put you on mute if you didn't see that. Um, Melissa Lavasani: all right, I'm off mute. Um, yeah, I think that Jay's hits the nail on the head with the collaboration thing. Um, I think that it's just a [00:25:00] problem across the entire ecosystem, and I think that's just a product of us being relatively new and upcoming field. Melissa Lavasani: Um, uh, it's a product of, you know. Our fundraising community is really small, so organizations feel like they are competing for the same dollars, even though their, their goals are all the same, they have different functions. Um, I think with time, I mean, let's be honest, like if we don't start collaborating and, and the federal government's moving forward, the federal government's gonna coordinate for us. Melissa Lavasani: And not, that might not necessarily be a bad thing, but, you know, we understand this issue to a whole other level that the federal government doesn't, and they're not required to understand it deeply. They just need to know how to really move forward with it the proper way. Um, but I think that it. It's really essential [00:26:00] that we all have this come together moment here so we can avoid things. Melissa Lavasani: Uh, I mean, no one's gonna die from bad advocacy. So like I've, I have a bit of an easier job. Um, but it can a, a absolutely stall efforts, um, to move things forward in Washington DC when, um, one group is saying one thing, another group is saying another thing, like, we're not quite at a point yet where we can have multiple lines of conversation and multiple things moving forward. Melissa Lavasani: Um, you know, for PMC, it's like, just let's get the first thing across the finish line. And we think that is, um, veteran healthcare. And, um, I know there's plenty of other groups out there that, that want the same thing. So, you know, I always, the reason why I put on the Federal Summit last year was I kind of hit my breaking point with a lack of collaboration and I wanted to just bring everyone in the same room and say like, all right, here are the things that we need to talk about. Melissa Lavasani: And I think the goal for this year is, um. To bring people in the same room and say, we talked about [00:27:00] we scratched the surface last year and this is where we need to really put our efforts into. And this is where the opportunities are. Um, I think that is going to, that's going to show the federal government if we can organize ourselves, that they need to take this issue really seriously. Melissa Lavasani: Um, I don't think we've done a great job at that thus far, but I think there's still plenty of time for us to get it together. Um, and I'm hoping with these two, uh, VA bills that are in the house right now and Senate is, is putting together their version of these two bills, um, so that they can move in tandem with each other. Melissa Lavasani: I think that, you know, there's an opportunity here for. Us to show the federal government as an ecosystem, Hey, we, we are so much further ahead and you know, this is what we've organized and here's how we can help you, um, that would make them buy into this issue a bit more and potentially move things forward faster. Melissa Lavasani: Uh, at this point in time, it's, I think that, [00:28:00] you know, psychedelics aren't necessarily the taboo thing that they, they used to be, but there's certainly places that need attention. Um, there's certainly conversations that need to be had, and like I said, like PMC is just one organization that can do this. Um, we can certainly organize and drive forward collaboration, but I, like we alone, cannot cover all this ground and we need the subject matter experts to collaborate with us so we can, you know, once we get in the door, we wanna bring the experts in to talk to these officials about it. Melissa Lavasani: So I. I, I really want listeners to really think about us as a convener of sorts when it comes to federal policy. Um, and you know, I think when, like for example, in the early eighties, a lot of people have made comparisons to the issue of psychedelics to the issue of AIDS research and how you have in a subject matter that's like extremely taboo and a patient population that the government [00:29:00] quite honestly didn't really care about in the early eighties. Melissa Lavasani: But what they did as an ecosystem is really organized themselves, get very clear on what they wanted the federal government to do. And within a matter of a couple years, uh, AIDS research funding was a thing that was happening. And what that, what that did was that ripple effect turned that into basically finding new therapies for something that we thought was a death, death sentence before. Melissa Lavasani: So I think. We just need to look at things in the past that have been really successful, um, and, and try to take the lessons from all of these issues and, and move forward with psychedelics. Joe Moore: Love that. And yes, we always need to be figuring out efficient approaches and where it has been successful in the past is often, um, an opportunity to mimic and, and potentially improve on that. Melissa Lavasani: Yeah. Jay Kopelman: One, one thing I think it's important to add to this part of the conversation is that, [00:30:00] you know, Melissa pointed out there are a number of organizations that are essentially doing the same thing. Jay Kopelman: Um, you know, I like to think we do things a little bit differently at Mission within Foundation in that we don't target any one specific type of service member. We, we work with all veterans. We work with first responders, but. What that leads to is that there are, as far as I've seen, nothing but good intentioned people in this space. Jay Kopelman: You know, people who really care about their patient population, they care about healing, they are trying to do a good job, and more importantly, they're trying to do good. Right? It, it, I think they all see the benefit down the road that this has, [00:31:00] pardon me, not just for veterans, but for society as a whole. Jay Kopelman: And, and ultimately that's where I would like to see this go. You know, I, I would love to see the VA take this. Take up this mantle and, and run with it and provide great data, great outcomes. You know, we are doing some data collection ourselves at Mission within foundation, albeit anecdotal based on surveys given before and after retreats. Jay Kopelman: But we're also working with, uh, Greg Fonzo down at UT Austin on a brain study he's doing that will have 40 patients in it when it's all said and done. And I think we have two more guys to put through that. Uh, and then we'll hit the 40. So there, there's a lot of good here that's being done by some really, really good people who've been doing this for a long time [00:32:00] and want to want nothing more than to, to see this. Jay Kopelman: Come to, come full circle so that we can take care of many, many, many people. Um, you know, like I say, I, I wanna work myself out of a job here. I, I just, I would love to see this happen and then I, you know, I don't have to send guys to Mexico to do this. They can go to their local VA and get the care that they need. Jay Kopelman: Um, but one thing that I don't think we've touched on yet, or regarding that is that the VA isn't designed for that. So it's gonna be a pretty big lift to get the right types of providers into the va with the knowledge, right, with the institutional knowledge of how this should be done, what is safe, what is effective, um, and then it, it's not just providing these medicines to [00:33:00] people and sending them home. Jay Kopelman: You don't just do that, you've gotta have the right therapists on the backend who can provide the integration coaching to the folks who are receiving these medicines. And I'm not just talking, I bga, even with MDMA and psilocybin, you should have a proper period of integration. It helps you to understand how this is going to affect you, what it, what the experience really meant, you know, because it's very difficult sometimes to just interpret it on your own. Jay Kopelman: And so what the experience was and what it meant to you. And, and so it will take some time to spin all that up. But once it's, once it's in place, you know, the sky's the limit. I think. Joe Moore: Kinda curious Jay, about what's, what's going on with Ibogaine at the federal level. Is there anything at VA right now? [00:34:00] Jay Kopelman: At the va? No, not with ibogaine. And, you know, uh, we, we send people specifically for IBOGAINE and five MEO, right? And, and so that, that doesn't preclude my interest in seeing this legislation passed, right? Jay Kopelman: Because it, it will start with something like MDMA or psilocybin, but ultimately it could grow to iboga, right? It the think about the cost savings at, at the va, even with psilocybin, right? Where you could potentially treat somebody with a very inexpensive dose of psilocybin or, or iboga one time, and then you, you don't have to treat them again. Jay Kopelman: Now, if I were, uh, you know, a VA therapist who's not trained in psychedelic trauma therapy. I might be worried [00:35:00] about job security, but it's like with anything, right? Like ultimately it will open pathways for new people to get that training or the existing people to get that training and, and stay on and do that work. Jay Kopelman: Um, which only adds another arrow to their quiver as far as I'm concerned, because this is coming and we're gonna need the people. It's just like ai, right? Like ai, yeah. Some people are gonna lose some jobs initially, and that's unfortunate. But productivity ultimately across all industries will increase and new jobs will be created as a result of that. Jay Kopelman: I mean, I was watching Squawk Box one morning. They were talking about the AI revolution and how there's gonna be a need for 500,000 electricians to. Build these systems that are going to work with the AI [00:36:00] supercomputers and, and so, Joe Moore: mm-hmm. Jay Kopelman: Where, where an opportunity may be lost. I think several more can be gained going forward. Melissa Lavasani: And just to add on what Jay just said there, there's nothing specific going on with Ibogaine at, at the va, but I think this administration is, is taking a real look at addiction in particular. Uh, they just launched, uh, a new initiative, uh, that's really centered on addiction treatments called the Great American Recovery. Melissa Lavasani: And, um, they're dedicating a hundred million dollars towards treating addiction as like a chronic treatable disease and not necessarily a law enforcement issue. So, um, in that initiative there will be federal grant programs for prevention and treatment and recovery. And, um, while this isn't just for psychedelic medicines, uh, I think it's a really great opportunity for the discussion of psychedelics to get elevated to the White House. Melissa Lavasani: Um, [00:37:00] there's also, previous to this announcement last week from the White House, there's been a hundred million dollars that was dedicated at, um, at ARPA h, which is. The advanced research projects, uh, agency for healthcare, um, and that is kind of an agency that's really focused on forward looking, um, treatments and technologies, uh, for, um, a, a whole slew of. Melissa Lavasani: Of issues, but this a hundred million dollars is dedicated to mental health and addiction. So there's a lot of opportunity there as well. So we, while I think, you know, some people are talking about, oh, we need a executive order on Iboga, it's like, well, you know, the, the president is thinking, um, about, you know, what issues can land with his, uh, voting block. Melissa Lavasani: And I think it's, I don't think we necessarily need a specific executive order on Iboga to call this a success. It's like, let's look at what, [00:38:00] um, what's just been announced from the White House. They're, they're all in on. Thinking creatively and finding, uh, new solutions for this. And this is kind of, this aligns with, um, HHS secretaries, uh, Robert F. Melissa Lavasani: Kennedy Junior's goals when he took on this, this role of Health Secretary. Um, addiction has been a discussion that, you know, he has personal, um, a personal tie to from his own experience. And, um, I think when this administration started, there was so much like fervor around the, the dialogue of like, everyone's talking about psychedelics. Melissa Lavasani: It was Secretary Kennedy, it was, uh, secretary Collins at the va. It was FDA Commissioner Marty Macari. And I think that there's like a lot of undue frustration within folks 'cause um, you don't necessarily snap your fingers and change happens in Washington dc This is not the city for that. And it's intentionally designed to move slow so that we can avoid really big mistakes. Melissa Lavasani: Um. [00:39:00] I think we're a year into this administration and these two announcements are, are pretty huge considering, um, you know, the, we, there are known people within domestic policy council that don't, aren't necessarily supportive of psychedelic medicine. So there's a really amazing progress here, and frustrating as it might be to, um, just be waiting for this administration to make some major move. Melissa Lavasani: I think they are making major moves like for Washington, DC These, these are major moves and we just gotta figure out how we can, um, take these initiatives and apply them to the issue of psychedelic medicines. Joe Moore: Thanks, Melissa. Um, yeah, it is, it is interesting like the amount of fervor there was at the beginning. You know, we had, uh. Kind of one of my old lawyers, Matt Zorn, jumped in with the administration. Right. And, um, you know, it was, uh, really cool to [00:40:00] see and hopeful how much energy was going on. It's been a little quiet, kind of feels like a black box a little bit, but I, you know, there was, Melissa Lavasani: that's on me. Melissa Lavasani: Maybe I, we need to be more out in public about like, what's actually happening, because I feel like, like day in and day out, it's just been, you gotta just mm-hmm. Like have that constant beat with the government. Mm-hmm. And, um, it's, it's, it's not the photo ops on the hill, it's the conversations that you have. Melissa Lavasani: It's the dinner parties you go to, it's the fundraisers you attend, you know? Mm-hmm. That's why I, I kind of have to like toot my own horn with PCs. Like, we need to be present here at, at not only on the Hill, not only at the White House, but kind of in the ecosystem of Washington DC itself. There's, it's, there are like power players here. Melissa Lavasani: There are people that are connected that can get things done, like. I mean, the other last week we had a big snow storm. I walked over to my friend's house, um, to have like a little fire sesh with them and our kids, and his next door neighbor came over. He was a member of Congress. I talked about the VA bills, like [00:41:00] we're reaching out to his office now, um, to get them, um, up to speed and hopefully get their co-sponsorship for, uh, the two VA bills. Melissa Lavasani: So, I mean, it, the little conversations you have here are just as important as the big ones with the photo ops. So, um, it, it's, it's really like, you know, building up that momentum and, and finding that time where you can really strike and make something happen. Joe Moore: Mm-hmm. Yeah. Jay, anything to add there? Jay Kopelman: Yeah, I was just gonna say that, you know, I, I, I think the fervor is still there, right? Jay Kopelman: But real life happens. Melissa Lavasani: Yes, Jay Kopelman: yes. And gets in the way, right? So, Melissa Lavasani: yeah, Jay Kopelman: I, I can't imagine how many issues. Secretary Kennedy has every day much less the president. Like there's so many things that they are dealing with on a daily basis, right? It, we, we just have to work to be the squeaky wheel in, in the right way, right. Jay Kopelman: [00:42:00] With the, with the right information at the right time. Like just inundating one of these organizations with noise, it's then it be with Informa, it just becomes noise, right? It it, it doesn't help. So when we have things to say that are meaningful and impactful, we do, and Melissa does an amazing job of that. Jay Kopelman: But, you know, it, it takes time. You know, it's, you know, we're not, this is, this is like turning an aircraft carrier, not a ski boat. Melissa Lavasani: Yeah, Joe Moore: yeah, absolutely. Um, and. It's, it's understandably frustrating, I think for the public and the psychedelic public in particular because we see all this hope, you know, we continue to get frustrated at politics. It's nothing new, right? Um, and we, we wanna see more people get well immediately. [00:43:00] And I, I kind of, Jay from the veteran perspective, I do love the kind of loud voices like, you're making me go to Mexico for this. Joe Moore: I did that and you're making me leave the country for the thing that's gonna fix me. Like, no way. And barely a recognition that this is a valid treatment. You know, like, you know, that is complicated given how medicine is structured here domestically. But it's also, let's face the facts, like the drug war kind of prevented us from being able to do this research in the first place. Joe Moore: You know? Thanks Nixon. And like, how do we actually kind of correct course and say like, we need to spend appropriately on science here so we can heal our own people, including veterans and everybody really. It's a, it's a dire situation out there. Jay Kopelman: Yeah. It, it really is. Um, you know, we were talking briefly about addicts, right? Jay Kopelman: And you know, it's not sexy. People think of addicts as people who are weak-minded, [00:44:00] right? They don't have any self-control. Um, but, but look at, look at the opioid crisis, right? That Brian Hubbard was fighting against in Kentucky for all those years. That that was something that was given to the patient by a doctor that they then became dependent on, and a lot of people died from that. Jay Kopelman: And, and so you, you know, it's, I I don't think it's fair to just put all addicts in a box. Just like it's not fair to put all veterans in a box. Just like it's not fair for doctors, put all their patients in a box. We're individuals. We, we have individual needs. Our, our health is very individual. Like, I, I don't think I should be put in the same box as every other 66-year-old that my doctor sees. Jay Kopelman: It's not fair. [00:45:00] You know, if you, if you took my high school classmates and put us all in a photo, we're all gonna have different needs, right? Like, some look like they're 76, not 66. Some look like they're 56. Not like they're, we, we do things differently. We live our lives differently. And the same is true of addicts. Jay Kopelman: They come to addiction from different places. Not everybody decides they want to just try heroin at a party, and all of a sudden they're addicted. It happens in, in different ways, you know, and the whole fentanyl thing has been so daggum nefarious, right? You know, pushing fentanyl into marijuana. Jay Kopelman: Somebody's smoking a joint and all of a sudden they're addicted to fentanyl or they die. Melissa Lavasani: I think we're having a, Jay Kopelman: it's, it's just not fair to, to say everybody in this pot is the same, or everybody in this one is the same. We have [00:46:00] to look at it differently. Joe Moore: Yeah. I like to zoom one level out and kind of talk about, um, just how hurt we are as a country, as a world really, but as a country specifically, and how many people are out of work for so many. Joe Moore: Difficult reasons and away from their families for so many kind of tragic reasons. And if we can get people back to their families and back to work, a lot of these things start to self-correct, but we have to like have those interventions where we can heal folks and, and get them back. Um, yeah. And you know, everything from trauma, uh, in childhood, you know, adulthood, combat, whatever it is. Joe Moore: Like these things can put people on the sidelines. And Jay, to your point, like you get knee surgery and all of a sudden you're, you know, two years later you're on the hunt for Fentanyl daily. You know, that's tough. It's really tough. Carl Hart does a good job talking about this kind of addiction pipeline and [00:47:00] a few others do as well. Joe Moore: But it's just, you know, kind of putting it in a moral failure bucket. It's not great. I was chatting with somebody about, um, veterans, it's like you come back and you're like, what's gonna make me feel okay right now? And it's not always alcohol. Um, like this is the first thing that made me feel okay, because there's not great treatments and there's, there's a lot of improvements in this kind of like bringing people back from the field that needs to happen. Joe Moore: In my opinion. I, it seems to be shared by a lot of people, but yeah, there's, it's, it's, IGA is gonna be great. It's gonna be really important. I really can't wait for it to be at scale appropriately, but there's a lot of other things we need to fix too, um, so that we can just, you know, not have so many people we need to, you know, spend so much money healing. Joe Moore: Mm-hmm. Jay Kopelman: Yeah. You ahead with that. We don't need the president to sign an executive order to automatically legalize Ibogaine. Right. But it would be nice if he would reschedule it so that [00:48:00] then then researchers could do this research on a larger scale. You know, we could, we could now get some real data that would show the efficacy. Jay Kopelman: And it could be done in a safe environment, you know? And, and so that would be, do Joe Moore: you have any kind of figures, like, like, I've been talking about this for a while, Jay. Like, does it drop the cost a lot of doing research when we deschedule things? Jay Kopelman: I, I would imagine so, because it'll drop the cost of accessing the medicines that are being researched. Jay Kopelman: Right? You, you would have buy-in from more organizations. You know, you might even have a pharma company that comes into this, you know, look at j and j with the ketamine, right? They have, they have a nasal spray version of ketamine that's doing very well. I mean, it's probably their, their biggest revenue [00:49:00] provider for them right now. Jay Kopelman: And, and so. You know, you, it would certainly help and I think, I think it would lower costs of research to have something rescheduled rather than being schedule one. You know it, people are afraid to take chances when you're talking about Schedule one Melissa Lavasani: labs or they just don't have the money to research things that are on Schedule one. Melissa Lavasani: 'cause there's so much in an incredible amount of red tape that you have to go through and, and your facility has to be a certain way and how you contain those, uh, medicines. Oh, researching has to be in a specific container and it's just very cumbersome to research schedule one drugs. So absolutely the cost would go down. Melissa Lavasani: Um, but Joe Moore: yeah, absolutely. Less safes. Melissa Lavasani: Yeah. Joe Moore: Yes. Less uh, Melissa Lavasani: right. Joe Moore: Locked. Yeah. Um, it'll be really interesting when that happens. I'm gonna hold out faith. That we can see some [00:50:00] movement here. Um, because yeah, like why make healing more expensive than it needs to be? I think like that's potentially a protectionist move. Joe Moore: Like, I'm not, I'm not here yet, but, um, look at AbbVie's, uh, acquisition of the Gilgamesh ip. Mm-hmm. Like that's a really interesting move. I think it was $1.2 billion. Mm-hmm. So they're gonna wanna protect that investment. Um, and it's likely going to be an approved medication. Like, I don't, I don't see a world in which it's not an approved medication. Joe Moore: Um, you know, I don't know a timeline, I would say Jay Kopelman: yeah. Joe Moore: Less than six years, just given how much cash they've got. But who knows, like, I haven't followed it too closely. So, and that's an I bga derivative to be clear, everybody, um mm-hmm. If you're not, um, in, in the loop on that, which is hopeful, you know? Joe Moore: Mm-hmm. But I don't know what the efficacy is gonna be with that compared to Ibogaine and then we have to talk about the kind of proprietary molecule stuff. Um, there's like a whole bunch of things that are gonna go on here, and this is one of the reasons why I'm excited about. Federal involvement [00:51:00] because we might actually be able to have some sort of centralized manufacturer, um, or at least the VA could license three or four generic manufacturers per for instance, and that way prices aren't gonna be, you know, eight grand a dose or whatever. Joe Moore: You know, it's, Jay Kopelman: well, I think it's a very exciting time in the space. You know, I, I think that there's the opportunity for innovation. There is the opportunity for collaboration. There's the opportunity for, you know, long-term healing at a very low cost. You know, that we, we have the highest healthcare cost per capita in the world right here in the us. Jay Kopelman: And, and yet we are not the number one health system in the world. So to me, that doesn't add up. So we need to figure out a way to start. Bringing costs down for a lot of people and [00:52:00] at the same time increasing, increasing outcomes. Joe Moore: Absolutely. Yeah. There's a lot of possible outcome improvements here and, and you know, everything from relapse rates, like we hear often about people leaving a clinic and they go and overdose when they get home. Tragically, too common. I think there's everything from, you know, I'm Jay, I'm involved in an organization called the Psychedelics and Pain Association. Joe Moore: We look at chronic pain very seriously, and IGA is something we are really interested in. And if. We could have better, you know, research, there better outcome measures there. Um, you know, perhaps we can have less people on opioids to begin with from chronic pain conditions. Um, Jay Kopelman: yeah, I, I might be due for another Ibogaine journey then, because I deal with chronic pain from Jiujitsu, but, Joe Moore: oh gosh, let's Jay Kopelman: talk Joe Moore: later. Jay Kopelman: That's self inflicted. Some people would say take a month off, but Melissa Lavasani: yeah, Jay Kopelman: I'm [00:53:00] not, I'm not that smart. Joe Moore: Yeah. Um, but you know, this, uh, yeah, this whole thing is gonna be really interesting to see how it plays out. I'm endlessly hopeful pull because I'm still here. Right. I, I've been at this for almost 10 years now, very publicly, and I think we are seeing a lot of movement. Joe Moore: It's not always what we actually wanna see, but it is movement nonetheless. You know, how many people are writing on this now than there were before? Right. You know, we, we have people in New York Times writing somewhat regularly about psychedelics and. Even international media is covering it. What do we have legalization in Australia somewhat recently for psilocybin and MDMA, Czech Republic. Joe Moore: I think Germany made some moves recently. Mm-hmm. Um, really interesting to see how this is gonna just keep shifting. Um Jay Kopelman: mm-hmm. Joe Moore: And I think there's no way that we're not gonna have prescription psychedelics in three years in the United States. It pro probably more like a [00:54:00] year and a half. I don't know. Do you, are you all taking odds? Melissa Lavasani: Yeah. I mean, I think Jay Kopelman: I, I gotta check Cal sheet, see what they're saying. Melissa Lavasani: I think it's safe to say, I mean, this could even come potentially the end of this year, I think, but definitely by the end of 2027, there's gonna be at least one psychedelic that's FDA approved. Joe Moore: Yeah. Yeah. Melissa Lavasani: If you're not counting Ketamine. Joe Moore: Right. Jay Kopelman: I, I mean, I mean it mm-hmm. It, it doesn't make sense that it. Shouldn't be or wouldn't be. Right. The, we've seen the benefits. Mm-hmm. We know what they are. It's at a very low cost, but you have to keep in mind that these things, they need to be done with the right set setting and container. Right. And, and gotta be able to provide that environment. Jay Kopelman: So, but I would, I would love, like I said, I'd love to work myself out of a job here and see this happen, not just for our veterans, [00:55:00] but for everybody. Joe Moore: Mm-hmm. Um, so Melissa, is there a way people can get involved or follow PMC or how can they support your work at PMC? Melissa Lavasani: Yeah, I mean, follow us in social media. Melissa Lavasani: Um, our two biggest platforms are LinkedIn and Instagram. Um, I'm bringing my newsletter back because I'm realizing, um, you know, there is a big gap in, in kind of like the knowledge of Washington DC just in general. What's happening here, and I think, you know, part of PC's value is that we're, we are plugged into conversations that are being had, um, here in the city. Melissa Lavasani: And, you know, we do get a little insight. Um, and I think that that would really quiet a lot of, you know, the, a lot of noise that, um, exists in the, our ecosystem. If, if people just had some clarity on like, what's actually happening or happening here and what are the opportunities and, [00:56:00] um, where do we need more reinforcement? Melissa Lavasani: Um, and, and also, you know, as we're putting together public education campaign, you know. My, like, if I could get everything I wanted like that, that campaign would be this like multi-stakeholder collaborative effort, right? Where we're covering all the ground that we need to cover. We're talking to the patient groups, we're talking to traditional mental health organizations, we're talking to the medical community, we're talking to the general population. Melissa Lavasani: I think that's like another area that we, we just seem to be, um, lacking some effort in. And, you know, ultimately the veteran story's always super compelling. It pulls on your heartstrings. These are our heroes, um, of our country. Like that, that is, that is meaningful. But a lot of the veteran population is small and we need the, like a, the just.[00:57:00] Melissa Lavasani: Basic American living in middle America, um, understanding what psychedelics are so that in, in, in presenting to them the stories that they can relate to, um, because that's how you activate the public and you activate the public and you get them to see what's happening in these clinical trials, what the data's been saying, what the opportunities are with psychedelics, and then they start calling their members of Congress and saying, Hey, there is this. Melissa Lavasani: Bill sitting in Congress and why haven't you signed onto it? And that political pressure, uh, when used the right way can be really powerful. So, um, I think, you know, now we're at this really amazing moment where we have a good amount of congressional offices that are familiar enough with psychedelics that they're willing to move on it. Melissa Lavasani: Um, there's another larger group, uh, that is familiar with psychedelics and will assist and co-sponsor legislation, but there's still so many offices that we haven't been able to get to just 'cause like we don't have all the time in the world and all the manpower in the world to [00:58:00] do it. But, you know, that is one avenue is like the advocates can speak to the, the lawmakers, the experts speak to the lawmakers, and we not, we want the public engaged in this, you know, ultimately, like that's. Melissa Lavasani: Like the best form of harm reduction is having an informed public. So we are not, they're not seeing these media headlines of like, oh, this miracle cure that, um, saved my family. It's like, yes, that can happen psychedelics. I mean, person speaking personally, psychedelics did save my family. But what you miss out of that story is the incredible amount of work I put into myself and put into my mental health to this day to maintain, um, like myself, my, my own agency and like be the parent that I wanna be and be the spouse that I wanna be. Melissa Lavasani: So, um, we, we need to continue to share these stories and we need to continue to collaborate to get this message out because we're all, we're all in the same boat right now. We all want the same things. We want patients to have safe and [00:59:00] affordable access to psychedelic assisted care. Um, and, uh. We're just in the beginning here, so, um, sign up for our newsletter and we can sign up on our website and then follow us on social media. Melissa Lavasani: And, um, I anticipate more and more events, um, happening with PMC and hopefully we can scale up some of these events to be much more public facing, um, as this issue grows. So, um, I'm really excited about the future and I'm, I've been enjoying this partnership with Mission Within. Jay is such a professional and, and it really shows up when he needs to show up and, um, I look forward to more of that in the future. Joe Moore: Fantastic. And Jay, how can people follow along and support mission within Foundation? Jay Kopelman: Yeah, again, social media is gonna be a good way to do that. So we, we are also pretty heavily engaged on LinkedIn and on Instagram. Um, I do [01:00:00] share, uh, a bit of my own stuff as well. On social media. So we have social media pages for Mission within Foundation, and we have a LinkedIn page for mission within foundation. Jay Kopelman: I have my own profiles on both of those as well where people can follow along. Um, one of the other things you know that would probably help get more attention for this is if the general public was more aware of the numbers of professional athletes who are also now pursuing. I began specifically to help treat their traumatic brain injuries and the chronic traumatic encephalopathy that they've, uh, suffered as a result of their time in professional sports or even college sports. Jay Kopelman: And, you know. I people worship these athletes, and I [01:01:00] think that if more of them, like Robert Gall, were more outspoken about these treatments and the healing properties that they've provided them, that it would get even more attention. Um, I think though what Melissa said, you know, I don't wanna parrot anything she just said because she said it perfectly Right. Jay Kopelman: And I'd just be speaking to hear myself talk. Um, but being collaborative the way that we are with PMC and with Melissa is I think, the way to move the needle on this overall. And like she said, if she could get more groups involved in, in these discussions, it would, it would do wonders for us. Joe Moore: Well, thank you both so much for your hard work out there. I always appreciate it when people are showing up and doing this important, [01:02:00] sometimes boring and tedious, but nevertheless sometimes, sometimes exciting work. And um, so yeah, just thank you both and thank you both for showing up here to psychedelics today to join us and I hope we can continue to support you all in the future. Jay Kopelman: Thank you, Joe. Thank you, Joe. It's a pleasure being with you today and with Melissa, of course, always Melissa Lavasani: appreciate the time and space. Joe Moore: Thanks.  

Trazemos nesta edição a aprovação de novos radiofármacos pela Anvisa por meio de um projeto de análise otimizada para reduzir gargalos na medicina nuclear. O boletim detalha o início da transição do tratamento de diabetes no SUS, com a substituição da insulina NPH pela glargina de longa duração para grupos prioritários. Destacamos também o papel da inteligência artificial e do monitoramento remoto como uma "segunda leitura" contínua para eletrocardiogramas fora do ambiente hospitalar. Acompanhe as atualizações que agilizam o acesso a insumos estratégicos e aprimoram o controle de doenças crônicas no seu podcast diário de atualização, com curadoria médica e produzido por IA.Afya News. Informação médica confiável e atualizada no seu tempo. Fontes do episódio aqui:⁠https://portal.afya.com.br/podcasts/afya-news/19-02-2026

⁠⁠⁠Enio Augusto⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ e ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Marcos Buosi⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ falam sobre tudo que envolve o mundo dos tênis e também de outros acessórios relacionados à corrida.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠SEJA MEMBRO DO CANAL!!!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Aqui tem análises, reviews, dicas, palpites, perguntas, respostas, números, valores e opinião. Informação com bom humor, dúvidas com resposta e conteúdo de sobra. Envie sua pergunta. Escute, aprenda, ensine e divirta-se com a gente.-Tudo sobre o Superblast 3 da Asics.-Cupom de Desconto:⁠⁠⁠⁠⁠⁠⁠⁠CORRA BARATO⁠⁠⁠⁠⁠⁠⁠⁠⁠ - PFC⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠KEEP RUNNING BRASIL⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ - PFChttps://www.instagram.com/keeprunningbrasil/https://www.youtube.com/@KeepRunningBrasilhttps://www.facebook.com/keeprunningbrasilhttps://www.linkedin.com/company/keep-running-brasil/https://www.instagram.com/keepers.run/-⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠SEJA MEMBRO DO CANAL NO YOUTUBE⁠⁠

Finalizando o nosso Especial de Carnaval, trazemos o alerta da Sociedade Brasileira de Infectologia sobre o aumento sazonal de infecções respiratórias, como a covid-19, decorrente das aglomerações e maior circulação viral do período. O conteúdo detalha as intercorrências comuns de pele e saúde íntima favorecidas pelo calor e umidade, além da tendência de crescimento nos diagnósticos de ISTs, como sífilis e gonorreia, nas semanas seguintes à folia. Acompanhe as orientações para a estruturação de triagens e o incentivo à testagem no pós-feriado no seu podcast diário de atualização, com curadoria médica e produzido por IA.Afya News. Informação médica confiável e atualizada no seu tempo.Fontes do episódio aqui:⁠https://portal.afya.com.br/podcasts/afya-news/18-02-2026

Neste segundo especial de Carnaval, o boletim aborda os riscos clínicos do calor extremo e da exaustão térmica em eventos de massa. O episódio destaca a importância de manter a suspeição de dengue mesmo no contexto festivo, reconhecendo sinais de alarme precocemente , e traz o alerta da American Heart Association sobre complicações cardiovasculares e hipertermia ligadas ao uso de drogas recreativas sob altas temperaturas. Acompanhe as orientações para o manejo de quadros agudos e a organização da rede assistencial no seu podcast diário de atualização, com curadoria médica e produzido por IA.Afya News. Informação médica confiável e atualizada no seu tempo.Fontes do episódio aqui:⁠https://portal.afya.com.br/podcasts/afya-news/17-02-2026

Nesta edição especial de Carnaval, o boletim detalha o alerta do Conselho Federal de Medicina sobre o impacto do consumo excessivo de álcool nas emergências e nos protocolos de trauma. O conteúdo apresenta as estratégias de prevenção combinada do Ministério da Saúde contra ISTs, com foco no acesso à PEP e na testagem rápida. Destacamos ainda a classificação do CDC para grandes aglomerações e os riscos de transmissão de doenças respiratórias e gastrointestinais durante a folia. Acompanhe as orientações que auxiliam na organização dos fluxos assistenciais e na segurança do paciente neste período no seu podcast diário de atualização, com curadoria médica e produzido por IA.Afya News. Informação médica confiável e atualizada no seu tempo.Fontes do episódio aqui:⁠https://portal.afya.com.br/podcasts/afya-news/16-02-2026⁠

The Deal You Never Knew Existed. Subscribe to our Newsletter: https://theultimatepartner.com/ebook-subscribe/ Check Out UPX: https://theultimatepartner.com/experience/ In this deep dive, Jay McBain reveals the harsh reality of the “28 Moments” in a modern B2B buying journey, using a multi-million dollar SAP deal at AstraZeneca as a wake-up call for vendors. He explains how traditional marketing leads are failing in the “decade of the ecosystem,” where trusted partners like NTT and SoftwareOne are winning deals in “light blue” partnership moments months before a customer ever downloads an ebook. If you aren’t visible in the seven-layer stack or collaborating with the partners who hold the customer’s trust, you aren’t just losing the deal—you're losing the entire market. https://youtu.be/NO-P6X2dTAo?si=8e_sVesqvwaC0M-E Key Takeaways Most vendors lose major deals without ever knowing a transaction was even taking place. The average considered purchase involves 28 distinct moments of research and influence before a sale. Trusted partners often close the deal in the “middle moments” months before the money is actually spent. Traditional marketing leads (MQLs) are often too “flimsy” compared to deep partner-led relationships. Winning in the ecosystem requires being part of a “seven-layer stack” of integrated technology and services. Data-sharing platforms like Crossbeam and Workspan are now essential to seeing the “invisible” pipeline. If you're ready to lead through change, elevate your business, and achieve extraordinary outcomes through the power of partnership—this is your community. At Ultimate Partner® we want leaders like you to join us in the Ultimate Partner Experience – where transformation begins. Key Tags: 28 Moments, Jay McBain, Ecosystem Strategy, AstraZeneca SAP Deal, Seven Layer Stack, B2B Buying Journey, Partner Ecosystem, NTT, SoftwareOne, Channel Strategy, Buyer Intent, Informa TechTarget, Collaborative Selling, Crossbeam, Partner Tap, Workspan, Marketplace Tracking, Co-selling, Tech Integration, Revenue Architecture, Pipeline Growth, Trusted Advisor, Digital Transformation, SAP Optimization, Microsoft AWS Competition. Transcript: [00:00:00] Jay McBain: So if you’re a vendor trying to get into that seven layer stack and you don’t have that relationship, or you don’t have the knowledge that NTT or software one is going in, this will have been a deal that would’ve never hit your pipeline and you’ll have no knowledge. So you will have lost this deal without knowing there was a deal. [00:00:19] Vince Menzione: We’ve been talking 28 moments, but you have a slide. I thought we’d spend some time here because, you know, every conversation with you is about 28 moments, but you finally took the time to analyze one of your deals or one of the deals that was going on with one of your clients and come up with the 28 moments. [00:00:36] Vince Menzione: I thought we’d spend a little time here because this journey slide is a wake up call. Uh, it’s, it’s, it’s all around. Why, why we need to think about all of those. Points we need to think about communities and analysts and marketplaces and proof of concepts and architecture and everything else. I thought maybe you’d take us through this a little bit. [00:00:53] Vince Menzione: ’cause this was for a client, AstraZeneca, by the way. This was, uh, if you don’t know this, ICI Americas was the precursor of mm-hmm. AstraZeneca. It was the first SAP customer in North America. [00:01:03] Jay McBain: Nice. I did [00:01:04] Vince Menzione: not know that. That’s why Microsoft and SAP both headquartered. In that area, near nearby, that client. [00:01:10] Vince Menzione: That’s, uh, news, new news. [00:01:11] Jay McBain: And by the way, this is an SAP deal we’re looking at. Yeah. Uh, so two things here. One is that, um, while I was declaring the decade of the ecosystem, you know, spending time with you and Boca, in between that time we got acquired. Canals, which was Latin for channel, got acquired by oia, part of Informa TechTarget, part of this bigger informa company, which is a Fortune 100 company outta the uk. [00:01:32] Jay McBain: Fantastic. You know, we’re part of this massive organization that is really around buyer intent. How, you know, a tech target and, uh, running hundreds of magazines like Information Week and Computer Week that customers and partners read running hundreds of events, the biggest events on the planet. [00:01:49] Vince Menzione: Crazy [00:01:49] Jay McBain: in B2B, like Black Hat and all these things are run by [00:01:52] Vince Menzione: Yeah, [00:01:53] Jay McBain: informa. [00:01:53] Jay McBain: So it’s got this massive mountain of data. About the 28 moments. So when you start to think if you’re a CMO and you start to think about the early moments, you, you think about somebody reading an ebook or, um, going to a, a webinar or going onto a LinkedIn live just like this one. Yeah, going to a major event and getting a pair of socks from you. [00:02:13] Jay McBain: Um, but anything early in the journey. These are the m qls. These are the things that I need enough of them to be credible before I hand them over to my sales team. ’cause I don’t wanna be laughed out of the room. Hey, they read an ebook. They must, AstraZeneca must be buying millions of dollars of stuff. [00:02:27] Vince Menzione: Traditional marketing lead. [00:02:29] Jay McBain: Traditional marketing lead. So they’re a bit nervous about sharing that. And then later on, the sales motions, the demos and all the progression of the sales. This was the two decades before us, the decade of sales, decade of marketing. But the 28 moments, just to take a step back, if you haven’t heard, it is just a considered purchase. [00:02:46] Jay McBain: It’s about psychology, human psychology. When you go and buy a car, second most expensive thing that you will purchase you on average will go through 28 moments getting ready for that purchase. Some people go through two moments and they just drive to the Cadillac dealership to see Larry, who’s been selling Cadillacs to the family for 80 years. [00:03:04] Jay McBain: Yep. Some people spend 58 moments. That’s probably me. [00:03:07] Vince Menzione: That’s you, a, [00:03:08] Jay McBain: you know, going through all the depreciation, watching every YouTube video, you know, going to the end of the earth. But the average is 28. So you start to think about this, this is the same buying a car considered purchase, that you would buy a million dollars in software. [00:03:21] Jay McBain: From Microsoft or SAP. So when you look at these moments, you start to think, you know, how is you before you buy that car, downloading the invoice price, downloading this month’s backend rebates. Should I buy it in January? Should I buy it in February? All these decisions you make before you get to that dealership, you’re smarter than the salesperson, smarter than the sales manager. [00:03:39] Jay McBain: You know what 5,000 people bought the car for within 50 miles of you? I mean, you’re just so smart. You actually don’t need the dealership anymore. Just Carvana to me, hand me the keys. Exactly. But now in buying technology, hardware, software services, customers are getting this smart. And here’s all the moments they take to get this smart. [00:03:57] Jay McBain: But the thing we always had in mind in this decade of the ecosystem was the 96% there are trusted people. Yeah. Spending decades building that trust that come in in critical moments. They’re not marketing moments, they’re not sales moments. They are fully partnership moments. Yeah. And they’re on this slide in light blue. [00:04:15] Jay McBain: So if you were to look at this deal and, and somebody in marketing is finding these eBooks and webinars and they think there might be something, AWS got a direct hit on their website. So there’s something brewing at AstraZeneca. It, it might be in, it’s a big pharmaceutical company, so you’re probably spending millions of dollars if something’s brewing. [00:04:31] Jay McBain: Yep. But guess what? At the same time, in December on this six month journey. Partners come in with five different paid projects, consulting, advisory design projects, and in this case it was NTT software one, Yash and uh, ISV was there. Yep. But NTT won three different. Deals right at that critical stage. It wasn’t Accenture, it wasn’t Deloitte, NTT at this particular department of AstraZeneca had spent the decades building those relationships. [00:04:58] Jay McBain: So they were the one, and they won critical part of this. And so that’s when the deal is won. And it’s not at April when the money’s being spent. Yeah, it’s, it’s not in March when a couple more ISVs joined the mix, that seven layer stack that solves this particular problem, it was right there. So if you’re a vendor trying to get into that seven layer stack and you don’t have that relationship, or you don’t have the knowledge that NTT or software one is going in, this will have been a deal that would’ve never hit your pipeline and you’ll have no knowledge. [00:05:30] Jay McBain: So you will have lost this deal without knowing there was a deal, which makes up again, the majority of your tam. [00:05:34] Vince Menzione: Yeah. [00:05:35] Jay McBain: But what if I did have this agentic ability to see this deal coming, and I’m a cybersecurity company, I’m just competing for layer five of the deal, but I know that it’s all happening in December. [00:05:46] Jay McBain: So the two things that jump out on this particular slide is one, they don’t just show up in December. [00:05:51] Vince Menzione: Yeah, [00:05:51] Jay McBain: this went closed one in their Salesforce CRM in August, September, well, before the customer ever read an ebook. So now you’re not dealing with a flimsy MQL. You’re dealing with a couple of great, you know, top partner 1000 sized firms. [00:06:09] Jay McBain: One of them is a partner, 30 firm. [00:06:11] Vince Menzione: Exactly. [00:06:12] Jay McBain: That is absolutely going into and earning hundreds of thousands of dollars in services to guide the customer to a millions of dollars in purchase. And, and you can imagine in that boardroom. With A CMO saying, Hey, I got this stuff here. And the head of channels or partnerships saying, no, no, this is real. [00:06:32] Jay McBain: Here’s the names, faces, and places. Yeah. And here’s how it’s happening. And this is exactly, this is the Gantt chart, this is the show up, this is the project, this is the outcome. This is exactly how it’s playing out. Now if I could go back and the board and the C-suite should be asking us, well, how many more deals like this can you see? [00:06:50] Vince Menzione: Yeah. [00:06:51] Jay McBain: If our TAM is, you know, how many billions of dollars? Could you double our pipeline by seeing more of these middle moments? And if we got a couple of months to spend with these partners before they get in front of the customer, could they build more of our portfolio into the deal so we’re not just layer five, maybe we’re layer three and layer five. [00:07:10] Vince Menzione: This slide screams at me. Integr Tech integration Cha. A partner channel integration of tech, uh, whether it’s Crossbeam, whether it’s Partner Tap, whether it’s work span, or any of these other technologies, tackle any of these technologies that are tracking marketplace, that are tracking partner to partner, co-selling. [00:07:30] Vince Menzione: Getting the integration points. The only way to really understand the situation here, because this is a multinational company. Yeah. It’s being touched at all PO points around the globe. And to understand who’s calling who, who’s influencing who, and getting a real view, you know, a uber view of what that looks like is super important. [00:07:47] Jay McBain: It is. And you know, if I’m trying to sell like a cross beam or partner tab or work span or something into my executive team, I’m just showing them this slide. [00:07:54] Vince Menzione: Exactly. [00:07:54] Jay McBain: Would you like to know about this deal? Like you see, October is the start of the timeline here. Would you like to know about this deal in August, September? [00:08:00] Vince Menzione: Yep. [00:08:01] Jay McBain: Would you like to know about it automatically? Again, we’re not waiting for somebody, a human in a cubicle to go fill out a form. We’re not waiting for them to call somebody at our in, in a cubicle at our company. Yeah. We’re literally age genically sharing platforms, and so when this triggers that AstraZeneca and now triggers in our CRM system as well, our team on AstraZeneca gets notified and it gets notified in September before the 28 moments even starts. [00:08:27] Jay McBain: This, the power of this, of doubling, tripling your pipeline and then winning a bigger yield, a bigger percentage of that pipeline. This is the holy grail of our industry, and no one’s gonna get to a hundred percent. You’re not gonna have a hundred percent of your tam covered by your pipeline. No one’s gonna win a hundred percent of that. [00:08:43] Jay McBain: But again, we only have to be 10 or 20% better than our competitors and we need to start moving on this now. [00:08:50] Vince Menzione: So your imperative for the partners here, well everyone watching here today, I mean, this screams to me build your ecosystem strategy in such a strong and succinct way. What else would you say to them? [00:09:00] Jay McBain: I mean, the second thing that jumps out, you see two AWS direct touches here. This is something that this would be inbound. This AWS would see this deal in their pipeline. [00:09:09] Vince Menzione: Yeah. [00:09:10] Jay McBain: Because the customer came to them. AWS lost this deal. Crazy. So Microsoft won this deal. I, I mentioned Microsoft outgrowing AWS Yeah. [00:09:19] Jay McBain: ’cause in this particular case, NTT and Software One and Yash came in with Microsoft. Yeah. To solve an SAP optimization, Microsoft, and, you know, seven layer deal. So whether you’re in AWS, whether you’re in Microsoft, whether you’re anywhere else in this industry, you’re thinking like, you’re not gonna probably overtake what happens in December. [00:09:39] Jay McBain: These are the most trusted, smartest people in the room. And whatever happens in those projects is the seven layer stack the customer’s gonna buy in March, April. So I, I start to think about this and go, I need to win. ’cause NTT has a wonderful relationship with AWS. [00:09:55] Vince Menzione: They do, [00:09:56] Jay McBain: I mean, partner of the year level. [00:09:57] Jay McBain: I mean, they’ve got 10,000 people certified. I mean, there’s just a, you know, there’s no one at AWS that, um, you know, would take a, a loss here because it’s a wonderful relationship. And Software One, they [00:10:09] Vince Menzione: go back to Microsoft actually 30, 40 years though they do. They were Dimension data before that. Yeah. [00:10:14] Vince Menzione: And they have the long hit Legacy And Software One. Software one as well. You, [00:10:19] Jay McBain: you know, well Software one is Microsoft’s biggest reseller, uh, in Europe. And now with Crayon, you know, one of the biggest in the world. So I would be nervous if I was looking at this and saw Software one coming in with NTT and watching these things take place if I were able to see this back in September, October and work with these companies. [00:10:38] Jay McBain: That’s where kind of Microsoft came into the picture. And this never hit Microsoft’s pipeline. No Microsoft salesperson ever worked on it, but millions of dollars came to Microsoft. Yeah. Uh, out of this deal. So there are examples of where Microsoft gets touched and AWS wins the deal. So this isn’t meant to say that it happens in every case, but it’s meant to say data rules the future, and agent ai, the ability to plumb in these boxes. [00:11:00] Jay McBain: Working with Informa tech, target people that can plumb in the boxes for you with third party data, helping you with the light blue boxes. We gotta be obsessed over these light blue boxes. [00:11:11] Vince Menzione: It’s incredible. The Ultimate Partner Winter Retreat is gonna be here in the Boca Studio. This is the third year that we’re gonna be here in Boca. [00:11:21] Vince Menzione: This is always a favorite of our community members, our executive members, our sponsors and speakers. We’ll all be here in the studio, which is a really intimate setting. We can see upwards of 40, 50 people. Uh, we’ll be hosting an incredible dinner at the Boca Resort overlooking the golf course. That’s an incredible property and, uh, we’d love to have you join us. [00:11:45] Vince Menzione: Thank you for being part of the ultimate Partner community, and I hope to see you this year at one of our events. Thank you.

Acompanhe nesta edição de domingo a Prescrição Cultural que destaca o cinema nacional com o filme "O Agente Secreto", estrelado por Wagner Moura, e o longa "Sinners", ambos indicados ao Oscar 2026. O conteúdo apresenta também uma curadoria musical que transita entre a sofisticação do jazz de Kamasi Washington e a energia da brasilidade contemporânea de Silva e BaianaSystem para este feriado de Carnaval. Aproveite estas indicações para renovar as energias e ampliar seu repertório humanístico no seu podcast diário de atualização, com curadoria médica e produzido por IA.Afya News. Informação médica confiável e atualizada no seu tempo.Fontes do episódio aqui:⁠https://portal.afya.com.br/podcasts/afya-news/15-02-2026⁠

Confira os destaques de Os Pingos nos Is desta sexta-feira (13):O ministro do STF Dias Toffoli é alvo de dez pedidos de impeachment apresentados no Senado, sendo que três requerimentos citam o caso do Banco Master como principal motivação. A abertura do processo depende de decisão do presidente da Casa e, embora prevista na Constituição, nunca foi aplicada no Brasil. Novo relator do caso Banco Master no STF, o ministro André Mendonça se reuniu com delegados da Polícia Federal para entender o estágio das investigações e alinhar procedimentos. Após assumir a relatoria por sorteio, ele deve analisar pedidos de parlamentares e avaliar a possibilidade de levantamento do sigilo do processo, que foi imposto anteriormente na Corte. Uma sessão reservada do STF sobre a relatoria do caso Banco Master teve forte tom político e discussão interna entre os ministros. Após divergências, Dias Toffoli deixou a condução do processo, que foi redistribuído a André Mendonça. A divulgação de diálogos da reunião gerou suspeitas de gravação clandestina, hipótese negada posteriormente pelo ministro. Uma lancha naufragou durante o trajeto entre Manaus e Nova Olinda do Norte, nas proximidades do Encontro das Águas. Informações preliminares indicam que ao menos 70 pessoas foram resgatadas e que a embarcação não possuía coletes salva-vidas. O Corpo de Bombeiros do Amazonas foi acionado e a ocorrência segue em andamento, sem confirmação oficial do número de vítimas e feridos. A deputada federal Adriana Ventura (Novo-SP) reúne assinaturas para protocolar uma proposta de emenda à Constituição que torna obrigatória a adoção de um código de conduta e integridade no Judiciário brasileiro, incluindo ministros do STF e de tribunais superiores. Para começar a tramitar, a PEC precisa de 171 assinaturas, e, segundo a assessoria da parlamentar, 46 apoios já foram obtidos. O ministro do Empreendedorismo, Márcio França, afirmou estar apto a disputar o governo de São Paulo nas eleições de 2026, mas destacou que a decisão final caberá ao presidente Lula. Outros nomes, como Fernando Haddad, Simone Tebet e Geraldo Alckmin, também são cotados para compor uma eventual chapa do PT no estado.O presidente Lula se reuniu com o senador Rodrigo Pacheco e voltou a defender que ele dispute o governo de Minas Gerais para fortalecer o palanque do PT em 2026. Apesar da insistência, o parlamentar manteve a indefinição sobre a candidatura e afirmou que só concorreria se não houvesse alternativa competitiva no estado. A Câmara dos Deputados analisa um projeto de lei que prevê o pagamento de um 13º salário para famílias beneficiárias do Bolsa Família. A proposta busca garantir um fim de ano com maior suporte financeiro aos inscritos no programa social, mas ainda depende de tramitação e aprovação no Congresso Nacional. O Tribunal Superior Eleitoral indicou que o presidente Lula (PT) ainda pode sofrer sanções relacionadas ao desfile da escola Acadêmicos de Niterói, que prestará homenagem ao político. Apesar de não impedir a apresentação, a Corte fez ressalvas e manteve o processo em aberto, permitindo que partidos acionem novamente o TSE caso entendam que houve ato eleitoral antecipado. Você confere essas e outras notícias em Os Pingos nos Is.

O balanço desta semana destaca o início da vacinação de 1,2 milhão de profissionais contra a dengue no Brasil e o alerta global da IARC sobre como infecções preveníveis, como HPV e hepatites, continuam associadas a parcela relevante dos cânceres. O episódio recapitula a resolução histórica da OMS sobre hemofilia , o combate do FDA a versões não aprovadas de medicamentos GLP-1 e os novos fluxos de urgência para o manejo do AVC na gestação. Acompanhe a síntese dos fatos que exigem maior preparo técnico e resiliência na prática médica no seu podcast diário de atualização, com curadoria médica e produzido por IA.Afya News. Informação médica confiável e atualizada no seu tempo.Fontes do episódio aqui:⁠https://portal.afya.com.br/podcasts/afya-news/14-02-2026

Esta edição apresenta as lideranças da lista TIME100 Health 2026 e os avanços em inteligência artificial e terapias que estão moldando o futuro da medicina. O boletim detalha o alerta da IARC sobre como a vacinação e o tratamento de infecções preveníveis, como HPV e Hepatite, são estratégicos para a redução global do risco de câncer. Destacamos também o uso de realidade virtual pela OPAS para o treinamento imersivo de profissionais em resposta a vírus respiratórios. Acompanhe as tendências que impactam a sua prática assistencial no seu podcast diário de atualização, com curadoria médica e produzido por IA.Afya News. Informação médica confiável e atualizada no seu tempo.Acesse o link das fontes aqui:https://portal.afya.com.br/podcasts/afya-news/13-02-2026

Prepare-se para a segunda metade do dia sabendo de tudo que mexeu com o mercado nas primeiras horas do pregão. Informação e análise com Roberto Motta. O Resumo da Manhã é transmitido de segunda a sexta, às 13h. Ative as notificações do programa e acompanhe ao vivo!

Interviul explorează mecanismele de putere din spatele scenei politice, subliniind existența unor influențe care controlează deciziile oficiale prin diverse pârghii de presiune; autorul analizează ascensiunea figurilor politice atipice, considerând că succesul acestora se bazează pe exploatarea frustrărilor populației și pe un discurs mai percutant decât cel al partidelor tradiționale; în plan economic, sunt semnalate riscurile investițiilor masive în inteligența artificială, care ar putea să nu genereze profitul scontat din cauza costurilor de întreținere subestimate; discuția evidențiază paradoxul sistemului fiscal românesc, care este prezentat ca fiind un mediu mult mai relaxat și mai atractiv pentru capital decât modelele rigide din Occident; o temă centrală este critica pasivității tinerei generații, invitatul deplângând faptul că mulți tineri aleg o stare de „anestezie” în locul dorinței active de a produce o schimbare reală în societate; se propune o schimbare de mentalitate colectivă, în care românii să înlocuiască obiceiul sabotajului reciproc cu efortul constructiv și colaborarea bazată pe obiective comune; în final, dialogul subliniază necesitatea asumării responsabilității individuale, oferind o lecție despre cum erorile trecutului trebuie folosite pentru a naviga mai prudent prin incertitudinile viitorului. IGDLCC înseamnă Informații Gratis despre Lucruri care Costă! Totul ne costă dar mai ales timpul așa că am făcut această serie pentru a mă informa și educa alături de invitați din domeniile mele de interes. Te invit alături de mine în această călătorie. Mi-am propus să mă facă mai informat și mai adaptat la schimbările care vin. Sper să o facă și pentru tine.

Confira no episódio de hoje o início da vacinação de 1,2 milhão de profissionais da atenção primária com o imunizante 100% nacional contra a dengue e o alerta do FDA sobre os riscos de segurança em versões não aprovadas de medicamentos GLP-1. O conteúdo apresenta também o debate sobre a necessidade de garantir que o avanço das tecnologias digitais em saúde seja acompanhado por equidade e inclusão real no cuidado. Acompanhe as atualizações que reforçam a segurança das equipes e a integridade da prescrição clínica no seu podcast diário de atualização, com curadoria médica e produzido por IA.Afya News. Informação médica confiável e atualizada no seu tempo.Confira o link das fontes aqui:https://portal.afya.com.br/podcasts/afya-news/12-02-2026

Eduardo Clark, subsecretario de Integración y Desarrollo del Sector Salud, Informa que actualmente hay 21 mil puntos de vacunación contra el sarampión en todo el país

Prepare-se para a segunda metade do dia sabendo de tudo que mexeu com o mercado nas primeiras horas do pregão. Informação e análise com Roberto Motta. O Resumo da Manhã é transmitido de segunda a sexta, às 13h. Ative as notificações do programa e acompanhe ao vivo!

Sportivii ruși nu au voie să participe la Jocurile Olimpice din acest an. Decizia vine după ce Rusia a invadat Ucraina. Cu toate acestea, unii sportivi au ajuns la probele din Italia. Au fost naturalizați de diferite state participante. De pildă, de Republica Moldova sau de România. Fenomenul naturalizării stârnește însă controverse. Detalii ne oferă Vitalie Cojocari în „Cronica lui Vitalie”. Temele ediției: - Conflictul din satul Dereneu, unde clerici ai bisericii ruse au agresat poliția și au intrat cu forța în biserica mitropoliei Basarabiei, subordonată Patriarhiei Române, continuă să rămână în atenția publică. Un conflict religios care testează reacția instituțiilor statului de drept. Valeria Vițu a urmărit subiectul. - Președinta Maia Sandu a vizitat autonomia găgăuză din sudul Republicii Moldova. Vizitele primilor persoane de la Chișinău s-au soldat în trecut ani cu proteste apropiate de violențe – în perioada în care autonomia era controlată de oligarhul Ilan Șor. De data aceasta, după ce autoritățile au destructurat rețeaua lui Șor, șefa statului a ținut un discurs la universitatea din Comrat cu sala plină, iar reacțiile sunt mai degrabă pozitive. Detalii, de la Liliana Barbăroșie. - Invitata Moldova Zoom este Veronica Garbuz, șefa Departamentului planificare și dezvoltare a întreprinderii de termoficare CET Nord, despre securitatea energetică a municipiului Bălți, despre cum consumatorii pot plăti de două ori mai puțin pentru facturile de energie și când se vor vedea investițiile în facturile oamenilor. - Președinta Maia Sandu și-a anunțat participarea la Conferința de Securitate de la München. - Premierul moldovean Alexandru Munteanu face o evaluare a primelor 100 de zile de mandat. - În Republica Moldova a fost înregistrată prima comunitate de energie din surse regenerabile. Știrile zilei: Președinta Maia Sandu, participă vineri și sâmbătă, 13-14 februarie, la Conferința de Securitate de la München, unul dintre cele mai importante forumuri internaționale dedicate securității globale. În marja conferinței, șefa statului moldovean va avea întrevederi bilaterale cu mai mulți omologi și oficiali de rang înalt, în cadrul cărora vor fi abordate subiecte ce țin de situația regională, cooperarea în domeniul securității și sprijinul pentru aderarea la Uniunea Europeană a Republicii Moldova, precum și pentru eforturile Republicii Moldova de a-și crește reziliența, anunță un comunicat al președinției.   Totodată, Maia Sandu va participa la un panel de discuții dedicat prevenirii și combaterii amenințărilor hibride, alături de prim-ministrul Regatului Suediei, Ulf Kristersson, președintele Serviciului Federal de Informații al Germaniei, Martin Jäger, și președintele Comitetului Militar al NATO, Giuseppe Cavo Dragone. În acest an, Conferința va reuni aproape 50 de șefi de stat și de guvern, precum și lideri ai principalelor organizații internaționale. Printre cei care au confirmat prezența sunt președinta Comisiei Europene, Ursula von der Leyen, cancelarul german Friedrich Merz, președintele Franței, Emmanuel Macron, premierul Poloniei, Donald Tusk, președintele Ucrainei Volodymyr Zelenskyy, președintele Lituaniei, Gitanas Nausėda, președintele Letoniei, Edgars Rinkēvičs, secretarul general al NATO, Mark Rutte, președinta Băncii Centrale Europene, Christine Lagarde, precum și președinta Băncii Europene de Investiții, Nadia Calviño. *** Premierul moldovean Alexandru Munteanu, declară, după primele 100 de zile de mandat, că Guvernul de la Chișinău acționează constant pentru a îndeplini 3 obiective majore – creșterea economică, accelerarea aderării la UE, pace și securitate acasă. Primele trei luni de mandat au marcat vizite externe în capitale importante, precum București, Bruxelles și Kiev. Economia Republicii Moldova dă semne de revigorare, spune premierul Munteanu. Dacă prognozele arătau o creștere de 2,2% pentru anul trecut, cifrele pentru 11 luni arată o creștere mai mare, de 2,7%. Inflația este în scădere, iar Banca Națională a Moldovei a redus repetat ratele de refinanțare. Tendința este susținută de o creștere bugetată cu 55 la sută a investițiilor pentru acest an. Procesul de integrare europeană avansează, Republica Moldova a deschis negocierile la nivel tehnic pentru 3 din cele 6 grupuri de capitole. Pe plan energetic, datorită interconectării cu piața europeană și cu România prin punerea în funcțiune în această vară a 4 linii electrice de tensiune joasă peste Prut, Republica Moldova a reușit să-și restabilească în câteva ore pana de curent națională de acum două săptămâni, când 70 la sută din țară a rămas fără electricitate din cauza bombardamentelor rusești în Ucraina. De asemenea, se lucrează la cele 3 linii de tensiune înaltă, interconexiuni cu România care vor asigura independența energetică deplină a Republicii Moldova. Guvernul coordonează proiecte de modernizare a infrastructurii, majoritatea din fonduri europene, atât în plan local, cât și la nivel de drumuri și infrastructură națională. Au fost lansate și consultări publice pentru pregătirea reformei administrației publice locale, una din cele mai ambițioase reforme ale acestui mandat, a mai spus premierul Alexandru Munteanu în raportul de activitate în primele 100 de zile. *** Prima comunitate de energie din surse regenerabile din Moldova a fost înregistrată în satul Cociulia, raionul Cantemir. Potrivit Agenției Naționale pentru Reglementare în Energetică, noua comunitate le va permite membrilor săi să producă, să consume, să stocheze și să partajeze energie electrică din surse regenerabile, transmite IPN. Comunitatea va funcționa pe principii de cooperare, oferind membrilor posibilitatea de a-și acoperi necesarul de curent prin producerea locală a energiei verzi. Entitatea a fost înscrisă oficial în Registrul comunităților de energie din surse regenerabile. *** Pentru prima dată după trei săptămâni de polei și ghețuș, circulația pe drumurile naționale se desfășoară în condiții bune în Republica Moldova. Autoritățile atenționează că, în nordul, centrul și sudul țării, pe alocuri, se înregistrează ceață, fenomen care poate reduce vizibilitatea și impune prudență sporită din partea conducătorilor auto. Odată cu încălzirea vremii, Inspectoratul pentru Situații de Urgență avertizează populația asupra pericolelor generate de instabilitatea stratului de gheață de pe râuri și lacuri. Deplasarea sau staționarea pe suprafețele acvatice înghețate poate deveni extrem de periculoasă, avertizează salvatorii.

Nesta edição, destacamos a resolução histórica aprovada pelo Conselho Executivo da OMS que reconhece a hemofilia e outros distúrbios hemorrágicos como prioridade global de saúde pública. O episódio aborda também o alerta da OPAS sobre a urgência de fortalecer a prevenção e o rastreamento do câncer do colo do útero nas Américas. Por fim, trazemos o debate sobre o impacto da comunicação médica pública na percepção de risco e adesão vacinal em cenários de ressurgimento de doenças como o sarampo. Acompanhe as notícias que moldam as políticas públicas e o cotidiano da sua prática no seu podcast diário de atualização, com curadoria médica e produzido por IA.Afya News. Informação médica confiável e atualizada no seu tempo.Acesse o link das fontes aqui:https://portal.afya.com.br/podcasts/afya-news/11-02-2026

Nesta edição, destacamos a resolução histórica aprovada pelo Conselho Executivo da OMS que reconhece a hemofilia e outros distúrbios hemorrágicos como prioridade global de saúde pública. O episódio aborda também o alerta da OPAS sobre a urgência de fortalecer a prevenção e o rastreamento do câncer do colo do útero nas Américas. Por fim, trazemos o debate sobre o impacto da comunicação médica pública na percepção de risco e adesão vacinal em cenários de ressurgimento de doenças como o sarampo. Acompanhe as notícias que moldam as políticas públicas e o cotidiano da sua prática no seu podcast diário de atualização, com curadoria médica e produzido por IA.Afya News. Informação médica confiável e atualizada no seu tempo.Acesse o link das fontes aqui:⁠https://portal.afya.com.br/podcasts/afya-news/11-02-2026⁠

Prepare-se para a segunda metade do dia sabendo de tudo que mexeu com o mercado nas primeiras horas do pregão. Informação e análise com Roberto Motta. O Resumo da Manhã é transmitido de segunda a sexta, às 13h. Ative as notificações do programa e acompanhe ao vivo!

O boletim de hoje destaca o debate global sobre a segurança e privacidade de dados no novo serviço ChatGPT Health. O episódio apresenta também a recomendação europeia para o estetrol (Fylrevy) como nova opção de terapia hormonal na pós-menopausa e os avanços promissores da terapia celular encapsulada para o tratamento do diabetes tipo 1. Acompanhe as notícias que influenciam a segurança digital e a inovação terapêutica no seu podcast diário de atualização, com curadoria médica e produzido por IA.Afya News. Informação médica confiável e atualizada no seu tempo.Acesso o link das fontes aqui:https://portal.afya.com.br/podcasts/carreira/10-02-2026

Comunicarea autentică este adesea confundată cu simplul schimb de informații, însă succesul acesteia depinde de depășirea iluziei că am fost înțeleși doar pentru că am vorbit. O barieră majoră o reprezintă utilizarea unui „limbaj” sau cod inadecvat, care trebuie adaptat constant la nivelul de școlarizare și așteptările interlocutorului. Responsabilitatea eșecului în comunicare îi revine întotdeauna emițătorului, care are datoria de a-și ajusta mesajul pentru a fi receptat corect. Percepția umană complică acest proces deoarece este empirică, învățată și, mai ales, selectivă, determinând oamenii să vadă lucruri diferite în aceeași realitate. Această subiectivitate poate crea conflicte ideologice profunde, unde indivizi cu viziuni opuse pot interpreta același concept în moduri total divergente. Pentru a naviga aceste obstacole, este necesară o „cultură a comunicării” ce include competențe lingvistice, pragmatice și discursive. În final, competența pragmatică ne permite să sincronizăm mesajul cu contextul și să menajăm imaginea celuilalt, transformând dialogul într-un instrument de armonizare socială. IGDLCC înseamnă Informații Gratis despre Lucruri care Costă! Totul ne costă dar mai ales timpul așa că am făcut această serie pentru a mă informa și educa alături de invitați din domeniile mele de interes. Te invit alături de mine în această călătorie. Mi-am propus să mă facă mai informat și mai adaptat la schimbările care vin. Sper să o facă și pentru tine.

A edição de hoje destaca o surto de norovírus nas Olimpíadas de Inverno de 2026 e a importância do diagnóstico sindrômico e da higiene em ambientes coletivos. Trazemos também a nova declaração da American Heart Association sobre a urgência do tratamento de AVC em gestantes e no pós-parto, reforçando a segurança dos exames de imagem durante a gravidez. Por fim, apresentamos as cinco grandes tendências globais que devem tornar os sistemas de saúde mais resilientes e focados na atenção primária para 2026. Acompanhe as notícias que moldam a segurança do paciente e a gestão clínica no seu podcast diário de atualização, com curadoria médica e produzido por IA.Afya News. Informação médica confiável e atualizada no seu tempo.Acesse o link das fontes aqui:⁠https://portal.afya.com.br/podcasts/carreira/09-02-2026

Nesta edição de domingo, a Prescrição Cultural traz a obra "A Coragem de Não Agradar", que explora a autonomia emocional e a responsabilidade pessoal através da psicologia adleriana. O conteúdo apresenta também o filme "One Life", um drama biográfico sobre escolhas éticas e coragem moral , e encerra com a sonoridade relaxante de Olivia Dean para baixar o cortisol. Aproveite estas indicações para fortalecer o seu bem-estar e ampliar o seu repertório humanístico no seu podcast diário de atualização, com curadoria médica e produzido por IA.Afya News. Informação médica confiável e atualizada no seu tempo.Acesso o link das fontes aqui:⁠https://portal.afya.com.br/podcasts/carreira/08-02-2026⁠

Neste resumo da semana, o episódio recapitula os fatos que moveram a medicina: a heterogeneidade do risco cardiometabólico desde a infância , as novas diretrizes da AHA para o manejo do AVC isquêmico e o uso de wearables na detecção de arritmias silenciosas. O conteúdo destaca ainda os avanços na prevenção oncológica com a cronoterapia e o impacto da inteligência artificial genômica no diagnóstico de doenças raras. Acompanhe o balanço das notícias essenciais para a sua prática assistencial e segurança jurídica no seu podcast diário de atualização, com curadoria médica e produzido por IA.Afya News. Informação médica confiável e atualizada no seu tempo.Acesso o link das fontes aqui:https://portal.afya.com.br/podcasts/carreira/07-02-2026

A Advocacia-Geral da União (AGU), sob o comando de Jorge Messias, impôs um novo cadeado na transparência do Governo Lula.O órgão reforçou o sigilo sobre o parecer do polêmico Projeto de Lei da Dosimetria, ignorando a Lei de Acesso à Informação (LAI). A justificativa oficial é de que o tema pode ser questionado futuramente no STF, o que, na visão da AGU, autorizaria a manutenção do documento longe dos olhos do público.Meio-Dia em Brasília traz as principais notícias e análises da política nacional direto   de Brasília.     Com apresentação de José Inácio Pilar e Wilson Lima, o programa aborda os temas mais quentes do cenário político e econômico do Brasil.     Com um olhar atento sobre política, notícias e economia, mantém o público bem informado.   Transmissão ao vivo de segunda a sexta-feira às 12h.   Apoie o jornalismo Vigilante: 10% de desconto para audiência do Meio-Dia em Brasília   https://bit.ly/meiodiaoa   Siga O Antagonista no X:  https://x.com/o_antagonista   Acompanhe O Antagonista no canal do WhatsApp. Boletins diários, conteúdos exclusivos em vídeo e muito mais.  https://whatsapp.com/channel/0029Va2SurQHLHQbI5yJN344  Leia mais em www.oantagonista.com.br | www.crusoe.com.br  

Novas revelações colocam o ministro da Justiça, Ricardo Lewandowski, em uma situação extremamente delicada. Informações apontam que, apenas um mês após ser nomeado para a pasta pelo presidente Lula, o ex-ministro do STF adquiriu um imóvel de luxo no valor de R$ 9,4 milhões.O agravante: o vendedor do imóvel é um empresário que se tornou alvo de investigações da Polícia Federal.Meio-Dia em Brasília traz as principais notícias e análises da política nacional direto   de Brasília.     Com apresentação de José Inácio Pilar e Wilson Lima, o programa aborda os temas mais quentes do cenário político e econômico do Brasil.     Com um olhar atento sobre política, notícias e economia, mantém o público bem informado.   Transmissão ao vivo de segunda a sexta-feira às 12h.   Apoie o jornalismo Vigilante: 10% de desconto para audiência do Meio-Dia em Brasília   https://bit.ly/meiodiaoa   Siga O Antagonista no X:  https://x.com/o_antagonista   Acompanhe O Antagonista no canal do WhatsApp. Boletins diários, conteúdos exclusivos em vídeo e muito mais.  https://whatsapp.com/channel/0029Va2SurQHLHQbI5yJN344  Leia mais em www.oantagonista.com.br | www.crusoe.com.br 

⁠⁠⁠Enio Augusto⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ e ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Marcos Buosi⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ falam sobre tudo que envolve o mundo dos tênis e também de outros acessórios relacionados à corrida.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠SEJA MEMBRO DO CANAL!!!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Aqui tem análises, reviews, dicas, palpites, perguntas, respostas, números, valores e opinião. Informação com bom humor, dúvidas com resposta e conteúdo de sobra. Envie sua pergunta. Escute, aprenda, ensine e divirta-se com a gente.-Tudo sobre a linha Hyperwarp da Mizuno.Hyperwarp Pure, Hyperwarp Elite e Hyperwarp Pro.-Cupom de Desconto:⁠⁠⁠⁠⁠⁠⁠CORRA BARATO⁠⁠⁠⁠⁠⁠⁠⁠ - PFC⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠KEEP RUNNING BRASIL⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ - PFChttps://www.instagram.com/keeprunningbrasil/https://www.youtube.com/@KeepRunningBrasilhttps://www.facebook.com/keeprunningbrasilhttps://www.linkedin.com/company/keep-running-brasil/https://www.instagram.com/keepers.run/-⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠SEJA MEMBRO DO CANAL NO YOUTUBE⁠⁠

Capitalismul nu este o destinație finală, ci mai degrabă un instrument care are nevoie urgentă de o „însănătoșire” etică pentru a trece de la simpla goană după profitul imediat la un model bazat pe virtuți și responsabilitate față de comunitate. Un lider adevărat în piață trebuie să fie o persoană virtuoasă, ghidată de prudență, care să înțeleagă că scopul unei companii este mult mai profund decât generarea de cifre seci pentru acționari. În acest context, România are un potențial uriaș și un viitor extrem de strălucit, mai ales dacă reușim să integrăm digitalizarea și să profităm de succesul sectorului nostru IT. Trebuie să învățăm că bogăția nu este o resursă finită, ci ceva ce poate fi creat prin inovație și muncă, depășind mentalitatea limitată a perioadei comuniste care viza doar subzistența. Tehnologia și inteligența artificială sunt motoare fantastice de creștere, însă avansul lor galopant ne obligă să fim extrem de vigilenți pentru a le menține în rolul de servitori utili. Avem nevoie de reglementări stricte și de o intervenție guvernamentală inteligentă, deoarece piața nu se poate autoregla singură atunci când miza este însăși esența umanității noastre. În final, lecția este simplă: dacă reușim să construim ecosisteme de afaceri bazate pe loialitate și etică, succesul financiar va veni natural, iar beneficiile vor fi resimțite de întreaga societate IGDLCC înseamnă Informații Gratis despre Lucruri care Costă! Totul ne costă dar mai ales timpul așa că am făcut această serie pentru a mă informa și educa alături de invitați din domeniile mele de interes. Te invit alături de mine în această călătorie. Mi-am propus să mă facă mai informat și mai adaptat la schimbările care vin. Sper să o facă și pentru tine.

Debate da Super Manhã: Com a expansão dos pagamentos eletrônicos, especialmente no Brasil com o sistema PIX, a segurança nas transações digitais tornou-se essencial. As atuais facilidades na forma como as pessoas e empresas transferem dinheiro e realizam pagamentos atraem a atenção de cibercriminosos. No debate desta quinta-feira (5), a comunicadora Natalia Ribeiro conversa com os nossos convidados para falar sobre as tecnologias de proteção para quem faz uso da internet para pagamentos, as ameaças digitais e dicas para evitar golpes e fraudes na internet. Participam o mestre em Ciência da Computação, especialista em Cyber Segurança, fundador do Centro de Excelência em Inteligência Cibernética e professor de Segurança da Informação da UFPE, Henrique Vila Nova; o doutor em Administração, especialista em Gestão e Segurança da TI e professor do curso de Ciências da Computação da UNINASSAU Graças, Humberto Caetano; e a advogada especialista em Proteção de Dados do Escobar Advocacia, Maria Wanick Sarinho.

De trei ani, Serviciul Român de Informații funcționează fără un director permanent. Lucian Pahonțu conduce Serviciul de Protecție și Pază de 21 de ani. Gabriel Vlase a mers la Formula 1 „în interes de serviciu”, în plină criză generată de interferențele rusești în alegerile prezidențiale din România. Toate acestea se întâmplă în timp ce România alocă serviciilor secrete bugete uriașe, chiar și în perioade de austeritate.În contextul noilor numiri la conducerea serviciilor de informații, anunțate de președintele Nicușor Dan, Răzvan Petri și Vlad Adamescu analizează mecanismele democratice prin care pot fi controlate serviciile secrete și motivele pentru care acestea nu sunt aplicate în România.Invitată: Emilia Șercan, despre legătura dintre plagiatele academice și infiltrarea serviciilor în politică.Surse: Zulean, M. (2025). Securitatea României între reformă, control civil și impostură, HumanitasGhincea, M. (2024). “Moștenirea lui Iohannis. Extinderea la infinit a conceptului de securitate națională.” LibertateaHuntington, S. P. (1957). The soldier and the state: The theory and politics of civil–military relations. Belknap Press of Harvard University PressGhincea, M., Zulean, M. (2024).”Protracted Transition: The Civilian Control Over the Military and Intelligence”. In: Stan, L., Vancea, D. (eds) Post-Communist Progressand Stagnation at 35. Palgrave MacmillanZulean, M. & Şercan, E. (2018). Democratic control of Romanian intelligence after three decades: quis custodiet ipsos custodes?. Defense & Security Analysis.#recorder #politicalaminut #sri

Facem un „zoom out” necesar asupra tensiunilor din Orientul Mijlociu, o regiune unde pacea promisă pare mai degrabă o iluzie, iar evenimentele recente ne arată că suntem abia la jumătatea unei povești extrem de complexe. Alături de Ioana Bercean, analizăm cum Israelul, deși o putere regională avansată, se confruntă cu limitele unui război de uzură și rămâne dependent de importurile de muniție, inclusiv din surse precum România.Realitatea este că nicio soluție sustenabilă nu poate apărea fără girul unei mari puteri care să garanteze acordurile, iar umbrela nucleară și influența Iranului adaugă straturi de complexitate care schimbă total regulile jocului diplomatic. Deși au existat victorii militare punctuale împotriva unor grupări precum Hezbollah, bătălia pentru empatia globală este mult mai greu de câștigat în fața brutalității conflictului din teren.Este fascinant să observi cum interesele marilor actori se aliniază uneori în mod neașteptat, așa cum vedem în cazul Rusiei și Statelor Unite în anumite regiuni, în timp ce Europa pare să aibă o putere de negociere limitată. În final, singura noastră armă eficientă rămâne educația și capacitatea de a ne folosi gândirea critică pentru a nu cădea în capcana etichetelor puse rapid pe rețelele sociale. Vă invit să priviți această analiză ca pe un proces de cunoaștere, pentru că doar prin dubiu și întrebări putem înțelege cu adevărat o lume aflată într-o transformare profundă. IGDLCC înseamnă Informații Gratis despre Lucruri care Costă! Totul ne costă dar mai ales timpul așa că am făcut această serie pentru a mă informa și educa alături de invitați din domeniile mele de interes. Te invit alături de mine în această călătorie. Mi-am propus să mă facă mai informat și mai adaptat la schimbările care vin. Sper să o facă și pentru tine.